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1 ABSTRACT 
Breast cancer is the most common cancer in women in Finland. It is often 
considered as a disease of affluent, Western societies with many known risk 
factors such as late age at first birth, small number of children, and sedentary 
lifestyle, among others. In addition, there are more novel exposures that are 
popular in modern Western societies and carry suspected carcinogenic 
potential, including use of hormonal contraceptives and personal use of hair 
dyes. The aim of the thesis was to evaluate the roles of such lifestyle factors 
and to assess how they contribute to the risk factor spectrum.  The thesis is 
composed of four sub studies; Study I estimating the association between the 
use of hormonal contraceptives and breast cancer risk and Study II aiming at 
determining whether the use of hair dyes independently increases risk of 
breast cancer. Study III estimated the proportion of women who had an 
opportunistic mammography before the age 50 years and assessed the roles 
of breast cancer family history and educational level in having a 
mammography. Study IV investigated the impact of major life events in 
breast cancer-specific mortality.  
Self-reported survey data was used as source of exposure information in 
all sub studies. Information on the outcomes of interest, namely breast 
cancer diagnosis and breast cancer-specific deaths were retrieved from the 
Finnish Cancer Registry. In Studies I and II, analyses by conditional logistic 
regression were conducted to estimate odds ratios (OR) and 95% confidence 
intervals (CI). In Study III, percentages of women reporting opportunistic 
mammography were calculated either directly of by Kaplan-Meier method. In 
Study IV, different Cox models were used to estimate breast cancer-specific 
mortality hazard ratios and 95 % confidence intervals.   
Use of hormonal intrauterine device (HR IUD) increased the risk of breast 
cancer in post-menopausal women by 52% (OR 1.52, 95% CI: 1.14-2.02), 
relative to users of copper IUD. Use of other hormonal contraception was by 
contrast associated with risk of breast cancer in younger women (OR 1.32, 
95% CI: 1.08-1.61), when compared to never-users. An OR of 1.23 (95% CI: 
1.11-1.36) was observed for women using hair dyes, relative to those who had 
never dyed their hair. Opportunistic mammography was also found to be 
very common, with more than 60% of responders reporting having had a 
mammography before screening age. Mammographies were also more 
common in women who had breast cancer family history and/or higher 
education. A large number of experienced negative life events was associated 
with 4% higher risk of breast cancer-specific mortality, some positive events 
accordingly lowering it.  
The prevalence of classical breast cancer risk factors, such as obesity and 
alcohol use have increased markedly over the past decades in Finland. Parity 
and total fertility are continuing to decline. These factors are more and more 
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commonly complemented by risk effects produced by use of exogenous 
hormones and cosmetics such as hair dye. Considering increasing usage, 
further research on the effects of HR IUD use is needed with other 
populations and a prospective study design. More research is also needed on 
the long-term effects of hair dye use. 
With respect to opportunistic mammography, it would be important to 
start registering the examinations to be able to take them into account in 
evaluation of the practices and effectiveness of organized screening. Women 
should also be more extensively informed of the harms of opportunistic 
mammography, such as accumulating radiation burden and the potential 
consequences of false positive or negative findings. The observed negative 
effects of negative life events and positive effects of some positive life events 
in breast cancer mortality give grounds for more holistic planning of 
treatment and patient follow up. 
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2 FINNISH SUMMARY 
Rintasyöpä on naisten yleisin syöpä Suomessa. Vaikka siitä selviytyminen on 
merkittävästi parantunut viime vuosina, on se edelleen myös suomalaisten 
naisten yleisin syöpäkuoleman syy.  
Rintasyöpää on usein pidetty rikkaiden, länsimaisten yhteiskuntien 
sairautena ja sen tunnettuja riskitekijöitä ovat muun muassa myöhäinen 
ensisynnytysikä, alhainen lasten lukumäärä ja vähäinen fyysinen aktiivisuus. 
Näiden lisäksi on joukko uudempia, rintasyövän kokonaisriskiin 
mahdollisesti vaikuttavia tekijöitä, joiden rooli on epäselvä. Tällaisia ovat 
esimerkiksi hormonaaliset ehkäisymenetelmät ja kosmetiikan, kuten 
hiusvärien, käyttö.  Tämän tutkielman tavoitteena oli muun muassa arvioida 
tällaisten elintapatekijöiden roolia rintasyövän etiologiassa, ja kuinka ne ovat 
osaltaan vaikuttamassa tämän päivän suomalaisen naisen rintasyövän 
riskitekijöiden kirjoon. 
Tutkielma koostuu neljästä osatyöstä. Ensimmäisen osatyön 
tarkoituksena oli arvioida hormonaalisten ehkäisyvalmisteiden käytön ja 
rintasyövän riskin välistä yhteyttä ja toisen osatyön tavoitteena oli selvittää, 
lisääkö hiusvärien käyttö itsenäisesti rintasyövän riskiä. Kolmannessa 
osatyössä arvioitiin kuinka suuri osa alle 50-vuotiaista naisista oli käynyt 
opportunistisessa mammografiassa ja missä määrin mahdollinen 
rintasyövän perhehistoria ja koulutustaso vaikuttivat käynti-innokkuteen. 
Neljännessä osatyössä selvitettiin merkittävien elämäntapahtumien 
vaikutusta rintasyöpäkuolleisuuteen.  
Kaikissa osatöissä käytettiin pääasiallisena altisteiden tietolähteenä 
Naisten terveys ja hormonien käyttö-kyselytutkimusta vuodelta 2009. 
Kolmannessa osatyössä hyödynnettiin lisäksi Elintavat, elämänlaatu ja 
terveys-kyselyitä, jotka toteutettiin vuosina 2012 ja 2013. Tiedot 
syöpätapauksista ja syöpäkuolemista saatiin Syöpärekisteristä.  
Hormonikierukkaa käyttäneiden post-menopausaalisten naisten 
rintasyövän riski oli kohonnut 52 % verrattuna kuparikierukan käyttäjiin. 
Muun hormonaalisen ehkäisyn käyttö vastaavasti lisäsi rintasyöpäriskiä 
nuoremmilla, enintään 50-vuotiailla naisilla 32 prosentilla, kun käyttäjiä 
verrattiin naisiin, jotka eivät käyttäneet hormonaalista ehkäisyä lainkaan.  
Hiusvärejä käyttäneiden naisten rintasyöpäriskin havaittiin olevan 23 % 
suurempi kuin naisilla, jotka eivät olleet koskaan värjänneet hiuksiaan.  Yli 
60 % kyselyihin vastanneista oli käynyt mammografiassa ennen 
seulontaikää. Mammografiat olivat myös yleisempiä naisilla, joilla oli 
rintasyövän perhehistoriaa ja/tai korkeampi koulutus. Suuri määrä koettuja 
kielteisiä elämäntapahtumia oli yhteydessä lievästi kohonneeseen 
rintasyöpäkuoleman riskiin, jotkin myönteisiksi koetut tapahtumat sitä 
vastoin alensivat rintasyöpäkuolleisuutta.  
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Monien klassisten rintasyövän riskitekijöiden esiintyvyys Suomessa on 
viime vuosikymmeninä merkittävästi lisääntynyt ja tätä joukkoa täydentävät 
yhä enenevässä määrin hormonaalisten ehkäisymenetelmien ja kosmetiikan 
käyttö. Ottaen huomioon hormonikierukan käytön lisääntyminen, sen 
vaikutuksista tarvitaan lisää tieteellistä näyttöä muilla tutkimusjoukoilla ja 
etenevällä tutkimusasetelmalla. Myös hiusvärien pitkäaikaisen käytön 
seurauksista ja elimistöön kertymisestä tarvitaan lisää tutkimuksia.  
Opportunististen mammografia-käyntien yleisyys antaa aihetta tämän 
tiedon systemaattiseen keräämiseen, jotta tietoja voidaan hyödyntää 
organisoidun rintasyövän seulontaohjelman käytänteiden ja vaikuttavuuden 
arvioinnissa. Naisia tulisi myös valistaa turhien mammografioiden haitoista, 
kuten säteilykuorman kasvamisesta ja mahdollisista väärän positiivisen tai 
negatiivisen löydöksen seurauksista.  
Havaitut kielteisten elämäntapahtumien kielteiset, ja myönteisten 
tapahtumien myönteiset vaikutukset rintasyöpäkuolleisuuteen antavat 
aiheen nykyistä kokonaisvaltaisempaan hoitojen suunnitteluun ja potilaan 
seurantaan, jossa psykososiaaliset tekijät huomioidaan aikaisempaa 
paremmin. 
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4 ABBREVIATIONS 
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5 INTRODUCTION 
Breast cancer is the most common cancer in women in Finland. Although 
survival from breast cancer has greatly improved in recent years, it remains 
the most common cause of cancer death among Finnish women1. 
Considering the high breast cancer prevalence worldwide2,  it is also likely to 
be one of the most studied cancer types. There is a long list of established risk 
factors contributing to breast cancer incidence, including many reproductive 
factors, family history of breast cancer, body mass index (BMI), physical 
activity and so forth. Regardless of extensive research and public health 
measures, breast cancer remains an indeterminate, life-threatening disease 
with many unknown factors. A great deal of effort has been put into both 
primary and secondary preventive measures in the form of identifying 
potential risk factors of breast cancer with extensive epidemiological and 
biomedical studies and with organized breast cancer screenings.   
The overall risk of breast cancer of a Finnish woman is likely to derive 
from dozens of contributing factors. It is also apparent that the risk factors 
and exposure to them are continuously changing, along with the changing 
environment. New environmental risk factors with possible carcinogenic 
effects emerge regularly and, due to rapid changes in lifestyle-related habits, 
they may have vast effects on the overall breast cancer risk. Good examples of 
such relatively novel exposures that are immensely popular in today’s 
Western societies are the use of hair dyes and extensive use of exogenous 
hormones. Also, chronic stress may be considered as such. Changes in 
health-related behavior have occurred also in other areas of life, as cancer 
prevention by organized screenings has become part of the routine health 
policy in Finland. Easy access to affordable mammography also outside the 
organized screening has led to massive popularity of so-called opportunistic 
screenings, and the consequences of such habits are unknown.  
The main aim of the thesis was to evaluate the roles of novel lifestyle-
related factors in breast cancer outcomes in Finland. These factors have 
increased in popularity over the past few decades and potentially contribute 
to the overall risk of – and survival from - breast cancer among Finnish 
women.  Another aim was to place these findings into larger cultural and 
societal contexts.  The studies explore potential associations between certain 
breast cancer risk factors, namely the use of hormonal contraceptives and 
hair dyes, and breast cancer incidence. The use of opportunistic 
mammography before screening age was also assessed, as were patterns of 
breast cancer-specific mortality with respect to pre- or post-diagnostic major 
negative and positive life events.  
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6 REVIEW OF THE LITERATURE 
6.1 EPIDEMIOLOGY OF BREAST CANCER  
Wade Hampton Frost described epidemiology as “something more than the 
total of its established facts. It includes their orderly arrangement into 
chains of inference, which extend more or less beyond the bounds of direct 
observation”3. The fast changing world with increasingly complex and 
multifaceted structures in society presents a challenge for epidemiologists. 
Resolving a full etiology of a disease is considered nearly impossible, and the 
“truth” must be composed of evidence from countless different sources. 
Dressler, a medical anthropologist, stated in his writings that disease risk 
varies in relation to culture as culture defines the context – the surrounding 
social and economic conditions.4 Dixon in turn summarized the concept of 
culture in health by stating that “culture can be causal, contributory or 
protective in relation to ill health”5. Figure 1  illustrates the 
multidimensional effect of culture on health and disease. While all the 
different levels of culture, from macro to micro, are interconnected, also the 
impact on health outcomes is diverse and multifaceted.  In addition to the 
pronounced effects of the cultural context on physical health outcomes, the 
mental well-being of the individual and community is also greatly influenced 
by it. 
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Figure 1.  Multidimensional effect of culture on health and disease. 
Source:  Dixon J, Banwell C, Ulijaszek S. When Culture Impacts Health. In: When Culture 
Impacts Health. Elsevier; 2013 [cited 2016 Apr 12]. p. 1–11. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/B9780124159211000014  
Breast cancer is the second most common cancer in the world, following 
lung cancer and it is the most common cancer in women in 140 countries. 
While it is more prevalent in the developed, high-income regions, the 
incidence rates are also steadily rising in less developed low- and middle-
income areas. Currently, the incidence is highest in Western and Northern 
Europe and in Northern America, and lowest in East Asia and Middle Africa 
(Figure 2). Overall, there is a greater than twofold difference in breast cancer 
incidence rates between less developed and highly developed countries.6 
The risk of breast cancer has increased in both developed and less 
developed countries until the 1980s, but has since levelled off or declined in 
some developed countries while continuing to increase in the less developed 
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areas7. It has been suggested that the somewhat lowered breast cancer 
incidence in parts of Europe and the United States is at least partly 
attributable to the decreasing use of hormone replacement therapy7. 
Smoothing in the incidence was observed also in some Nordic countries in 
2003-2009, not however in Finland, and the trend in all Nordic countries 
has turned upwards in recent years8.  
While developed countries have high breast cancer incidence, they also 
have low breast cancer mortality in relation to incidence (Figure 3)2. This 
phenomenon can be seen from the mortality-to-incidence ratios (MI ratios) 
presented by Forouzanfar and colleagues in a large systematic analysis of 
breast and cervical cancer in 187 countries between 1980 and 2010. The 
breast cancer MI ratios of women in developed countries are lower than 
those of women in less developed countries. The ratios for both developed 
and less developed countries have decreased steadily since the mid-1980s, 
but the difference in the ratios between the countries has remained more or 
less the same over time.9 In 2008, Porter reported the breast cancer MI ratio 
to be 0.69 in Africa, as compared with 0.19 in North America10.  
Declined breast cancer mortality rates observed especially in the 
developed countries are considered to result from a combination of improved 
detection and earlier diagnosis through population-based screening and 
more effective treatment regimens, such as adjuvant hormonal treatment 
and introduction of second- and third-generation chemotherapy agents and 
aromatase inhibitors6,7.  
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Figure 3.  Estimated age-standardized (World) rates of breast cancer per 100,000 persons 
Source: GLOBOCAN 2012 (IARC), Section of Cancer Surveillance (Accessed 17/1/2017). 
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx 
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As with most cancers, also the risk of breast cancer increases with age7,11. 
With respect  to histology, some 70% of breast cancers are ductal carcinomas, 
and 15% lobular carcinomas with other more infrequent types accounting for 
the rest of the cases7. Breast cancer cannot thus be considered a single 
disease as it is very heterogeneous, both clinically and morphologically. The 
WHO classification of tumors of the breast recognizes over 20 different 
breast cancer subtypes. Generally, the prognosis is good if the disease is 
detected at an early stage.7 Although the stage and grade at diagnosis 
correlate with survival from breast cancer, patients with a similar cancer type 
may have a very different response to therapy or long-term outcome6. 
6.2 BREAST CANCER IN FINLAND 
There were 5008 incident breast cancers and 815 breast cancer deaths in 
Finland in 2014, as registered at the Finnish Cancer Registry (FCR)1. 
Incidence increases significantly after 45 years of age, the average age at 
diagnosis being 60 years12. Overall lifetime risk of breast cancer of a Finnish 
woman by the age of 75 years is about 10%8. In Finland, some 60% of breast 
cancers are  localized (not metastasized) at diagnosis13.  According to recent 
estimations, the 5-year relative survival of breast cancer patients was 90%1,14. 
Figure 4 illustrates the time trends of breast cancer incidence and mortality 
in Finland in 1955-2014 as rates per 100 000 persons.  The initiation of the 
nationwide organized breast cancer screening in 1987 can be seen as a steep 
rise in the incidence curve and correspondingly, a decrease in mortality in 
the late 1980s. The rationale and organization of the nationwide breast 
cancer screening program in Finland are explained in detail in Section 6.2.1.  
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Figure 4.  Time trends of breast cancer incidence and mortality in Finland in 1955-2014, age-
standardized (World) rates per 100 000 persons. 
Source: Finnish Cancer Registry Statistics, tilastot.syoparekisteri.fi. Information as of 
16.11.2016, accessed 25.1.2017. 
6.2.1 BREAST CANCER SCREENING 
According to the early writings of Wilson and Jungner (1968), “The object of 
screening for disease is to discover those among the apparently well who 
are in fact suffering from disease. They can then be placed under treatment 
and, if the disease is communicable, steps can be taken to prevent them 
from being a danger to their neighbours. In theory, therefore, screening is 
an admirable method of combating disease, since it should help detect it in 
its early stages and enable it to be treated adequately before it obtains a 
firm hold on the community.”15. 
Organized, population-based breast cancer screening has since proven 
effective in developed countries in terms of detecting cancers at a lower stage 
and subsequent decreased cancer-specific mortality16.  The balance of harms 
and benefits of mammography breast cancer screening is, however, under 
continuous debate. Overdiagnosis and false-positive findings may lead to 
unnecessary examinations and treatment, doing more harm than good. 
Emotional and quality-of-life effects are also often discussed, although they 
are much more difficult to measure.17,18  Regardless of evidence concerning 
the harms of overdiagnosis, it is still considered that the benefits, namely 
reduced breast cancer mortality, of population-based organized breast cancer 
screening override the harms19.  Organized breast cancer screenings were 
initiated in Europe in the late 1980s. By 2012, screening programs were 
running or being established in 24 countries in the European Union.6   
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In Finland, a national organized breast cancer screening program was 
launched in 1987. The program was initiated gradually; first cohorts of 
women born in even years were invited to screening and women born in odd 
years were used as controls. By 1992, all women aged 50–59 years received 
screening invitations every second year, and during the early years of 
organized screening the coverage was nearly 100%.  By 2007, the upper age 
of invitations was set at 69 years and biennial screenings covered the whole 
country.20,21 Overall, the participation rate today is close to 85% and nearly 
one-third of all incident breast cancers in Finland are detected in the 
organized screening. More than half of the invasive cancers in women of 
screening age were detected by screening.22 According to the evaluation in 
2008, breast cancer mortality was reduced by 22% in 1992-2003 among the 
screening invitees aged 50-69 years at death. Accordingly, among all women 
aged 60-79 years at death, the greatest reduction in breast cancer mortality, 
28%, was estimated in municipalities inviting 50- to 69-year-old women to 
screening on a regular basis.23 Organized screening has thus proved to be an 
efficient public health intervention and has contributed to timely diagnosis 
and improved breast cancer survival in Finland. 
6.3 BREAST CANCER AS A PHENOMENON OF 
WESTERN SOCIETY  
The World Health Organization (WHO) states that “breast cancer is a 
disease of affluent societies that have acquired a “Western lifestyle”, 
characterized by high-calorie diet rich in animal fat and proteins, combined 
with lack of physical exercise.” Such regions include e.g. Australia, North 
America and Northern Europe, where the plateau of incidence has already in 
part been reached. Conversely, countries that have only recently become 
industrialized and affluent show a marked increase in incidence and 
mortality, including countries such as India, Japan and the Republic of 
Korea.7  
After the founding of the WHO in 1948, many international and cross-
cultural health initiatives were launched and it was soon shown that several 
health-related issues and problems had as much a social and cultural aspect 
as a biological one. Social and cultural factors seemed to have a great impact 
on health behavior and consequently, health outcomes.24 However, although 
cultural models are shared within a society by definition, considerable 
differences may exist between individuals in adherence to the models. 
Different levels of knowledge of a certain cultural domain, different social 
context of the occasion, and personal circumstances, e.g. economic or 
physical restraints, all play a role, enhancing the complex impact of 
social/cultural factors on health.25 
Some of the well-known factors contributing to the higher breast cancer 
incidence in Western societies than in less developed regions are low 
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birthrate, older age at first delivery, and obesity10. The ideal of a small 
nuclear family and higher age at first birth leads to a situation, where 
continuous contraception is needed for years, even decades. Additionally, 
there are likely to be other lifestyle-related factors that in part affect the 
higher breast cancer incidence in Western societies. Cultural norms related 
to appearance are ever-evolving and modifying one’s looks by, for instance, 
hair dyeing is increasingly popular. Even if the idea of changing hair color is 
known all over the world, it is commonly considered a Western society 
phenomenon.  
Multifaceted Western societies with schedule-oriented, demanding, and 
hectic lifestyles may also produce stress and anxiety. Many major life events 
are common worldwide, but coping mechanisms vary, also by cultural 
framework and background26. There is naturally variation also in the types of 
events and the frequency at which they occur in different societies. Certain 
major life events have become less common in developed countries and 
others simultaneously more prevalent. Premature deaths of children and 
spouses have become rare, while e.g. divorces and problems related to work 
and employment are likely to be more common and may have profound 
effects on a person’s life.  
A question has been raised as to whether breast cancer in the Western 
world is in fact the same disease as it is in, for instance, Asian countries, 
where the increase in breast cancer incidence has lately been the greatest in 
the world. The incidence of breast cancer in Asia peaks at 40-50 years, 
whereas in Europe it does so at 60-70 years of age, although the prevalence 
of BRCA1/2 mutations is assumed not to differ markedly.27,28 If distinct 
genetic backgrounds do not explain the variation in age at disease onset, the 
reason must be elsewhere. Leong et al. concluded that “the observed 
differences are most likely attributable to different risk factors acting 
differentially on two (or more) different types of breast cancer”27.  Estrogen 
receptor-negative breast cancers are more prevalent in developing countries, 
and it has been suggested that this may in part explain the higher breast 
cancer mortality in these regions. Also, the lack of population-based 
organized screenings may contribute to it, in addition to behavioral aspects.10 
Although more attention has recently been directed to investigating disease 
risks within and between different social and ethnic groups, the cultural 
dimensions framing them and contributing to them are still not well 
understood25. 
When it was observed that the obvious changes in health behaviors, such 
as increased smoking prevalence or changes in diet only explained a small 
portion of the association between modernization and risk of certain 
diseases, the medical anthropologists focused their interest on the potential 
social stresses of culture change. The aim was to identify the socially and 
culturally relevant stressors affecting health. Already in the 1960s, Cassel and 
colleagues suggested that higher disease rates among migrants entering a 
new community may be a result of the experienced stress from “cultural 
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incongruity”, the high stress levels in turn resulting in poorer health3. The 
same phenomenon is likely to also apply to culture change within a society, 
regarding e.g. modernization in Western societies, when people need to 
adapt to a rapidly changing environment and mode of behavior. Also some 
biological anthropologists have suggested that disease occurrence can be 
seen as a marker for maladaptation to such changes25. 
6.4 KNOWN RISK FACTORS OF BREAST CANCER 
Age is the most pronounced risk factor of breast cancer. The cumulative 
incidence among women in Europe is 2.7% by age 55, 5.0% by age 65, and 
7.7% by age 7511. After age, most of the contributing risk factors are assumed 
to be environmental. Studies of migrating populations have indicated that 
the breast cancer risk of the migrant population approaches that of the host 
country within one or two generations. This evidence together with the 
observed geographical variations and time trends suggest that environmental 
risk factors play a remarkable role in the etiology of breast cancer7. Many of 
the other known breast cancer risk factors are related to endogenous female 
hormones.  Having more children, breastfeeding, and being young at first 
delivery decrease the risk, whereas young age at menarche and old age at 
menopause are known to increase the risk. All of these factors affect the 
number of lifetime menstrual cycles and the consequent cumulative exposure 
to ovary-modulated endogenous hormones stimulating cell growth in the 
mammary glands29. Even though parity overall has protective effects against 
breast cancer, the risk is elevated during pregnancy and soon after, owing to 
the high levels of circulating hormones30,31. Also, the beneficial effect of 
young age at first full-term pregnancy appears to be limited to hormone 
receptor-positive breast cancer32,33. 
Alcohol consumption and postmenopausal weight gain are known to 
increase the risk of breast cancer,  with physical activity, by contrast, 
lowering it11,12.  The mechanism behind the carcinogenic effect of alcohol use 
is not fully understood, but it is assumed that at least part of it comes directly 
from the carcinogenicity of ethanol and its metabolites, the interactions with 
folate metabolism and the estrogen pathway possibly also being 
involved6.  The adverse effect of postmenopausal weight gain, in turn, is 
likely to be directly related to increased levels of circulating estradiol. The 
influence of physical activity is, at least in part, through its benefits on weight 
control. It is, however, probable that it also acts independently of its effects 
on BMI, likely through hormonal changes.6 
Use of hormone replacement therapy, most specifically combined 
estrogen-progestogen therapy is also known to be a risk factor for breast 
cancer through various, complex hormonal systems34,35. 
Certain occupational exposures, such as night shift work, have been 
suggested to be associated with elevated breast cancer risk by disrupting the 
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natural circadian rhythm, and the International Agency for Research on 
Cancer (IARC) has classified shiftwork as possibly carcinogenic to 
humans36,37. A recent meta-analysis, however, questioned this association as 
the authors found no evidence of a relationship between night shift work and 
breast cancer incidence in the combined analysis38.  
Some benign breast diseases 39, higher breast density40, and radiation 
treatment at a younger age41,42 have been found to increase breast cancer 
risk. Exposure to ionizing radiation in repeated mammography is also 
suggested to increase breast cancer risk43,44, however the benefits of 
mammographic screening are considered to outweigh the consequential 
harms45. Estimates of the magnitude of the associations are listed in Table 1, 
as summarized by Key et al.11 
In studies on the heritability of breast cancer, it is estimated that 
heritability explains about 30% of the variation in breast cancer risk, the 
remaining 70% being attributable to several environmental risk factors46,47. 
Thus, approximately one-third of the variation in breast cancer risk in a 
population can be accounted for by interindividual genetic differences. As the 
authors highlight, this estimate includes both cancer-specific genetics and 
genetic contributions to some cancer risk factors, such as obesity, that have a 
genetic component.46 Although genetic factors overall are presumed to play a 
rather small role in the etiology of breast cancer, mutations in BRCA1 or 
BRCA2 genes remarkably increase the risk of breast cancer, most specifically 
in early-onset disease. One affected first-degree relative doubles the risk and 
the risk increases further with more known affected relatives48–50. A mutation 
in either BRCA1 or BRCA2 gene increases a woman’s lifetime breast cancer 
risk to some 50-65%51,52. It has been estimated that germline mutations 
explain some 5-10% of all new breast cancer cases, mutations in BRCA1/2 
accounting for about 25-30% of these53,54. 
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Table 1. Estimated effects of some known breast cancer risk factors  
Risk factor Estimated change in risk 
Number of full-term pregnancies, ≥5 vs. none -50% 
Breastfeeding, ≥25 mo. vs. never -33% 
Physical activity, heavy exercise few hours/week vs. none -30% 
Parity vs. nulliparity -25% 
Menarche, each 1-year delay -5% 
Menopause, each 1-year delay +3% 
Alcohol, per each 10g unit per day +10% 
Combined oral contraceptives, current vs. never use +25% 
Hormonal therapy for menopause, 10 year use vs. never +35% 
Obesity, post-menopausal BMI >30 +50% 
Ionizing radiation, 1 Gy vs none +10-170% 
Family history, yes vs. none +100% 
Benign breast disease (proliferative lesions) vs. none +100-300% 
 
Source: Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001 
Mar;2(3):133–40. 
Population attributable fraction describes the excess risk of the exposed in 
the study population in relation to the total risk of the disease in the whole 
population. Some population attributable fractions of environmental breast 
cancer risk factors are presented in Table 2, as estimated by Parkin et al. in a 
large study in the UK on the roles of different environmental exposures in the 
incidence of cancer55. Another study on the population attributable risks for 
certain modifiable breast cancer risk factors estimated that the use of 
exogenous hormones accounts for some 19%, and physical inactivity for 13% 
of breast cancer risk. A set of non-modifiable breast cancer risk factors, 
including age at menarche and menopause, parity, family history of breast 
cancer, and a benign breast disease was estimated to account for 37% of all 
invasive breast cancers in the study.56  
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Table 2. The percentages of incident breast cancers attributable to certain environmental risk 
factors.  
Exposure (optimum exposure level)) % of breast cancers 
attributable to the specific 
risk factor exposure 
Overweight and obesity (BMI?25 kg/m2) 8.7 
Alcohol (none) 6.4 
Occupational exposures (none) 4.6 
Physical exercise (?30 min 5 times per week) 3.4 
Post-menopausal hormones (none) 3.2 
Breastfeeding (minimum of 6 months) 3.1 
Ionizing radiation (none) 0.9 
 
Source: Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and 
environmental factors in the UK in 2010. British Journal of Cancer. 2011 Dec 6;105:S77–81. 
6.5 LESS STUDIED LIFESTYLE-RELATED RISK 
FACTORS  
Among others, the vast use of chemicals, the overall medicalization of the 
society, and health effects of different types of life events are less commonly 
studied potential risk modifiers of breast cancer.  Related to the first, we 
investigated the effects of hormonal contraceptives and hair dye use on the 
risk of breast cancer. Regarding medicalization, also the prevalence of 
opportunistic mammography in Study III was considered a surrogate marker 
in an effort to examine the phenomenon in the Finnish society. Study IV 
focused on life stresses, but also investigated the potential beneficial effects 
of positive developments in life, which especially has been lacking scientific 
evidence. 
6.5.1 CHEMICALS; HORMONES AND COSMETICS  
Use of chemicals in modern societies is at an entirely different level than it 
was a century ago. Exposures to chemicals in our daily lives through food and 
water, cosmetics, detergents, pesticides, medicines, plastic goods, 
chemically-treated clothing, work-place exposures and so forth is likely to 
create a massive burden of exogenous chemicals in the body57,58.  Related to 
this, Studies I and II investigated the use of hormonal contraceptives and 
hair dyes and their possible relationships with the risk of breast cancer. 
In the Western world, short-acting and reversible contraception methods 
are the most commonly used, in contrast to the long-acting, highly effective 
clinical methods used most in developing regions. Contraceptive pill is the 
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most commonly used method of contraception in Northern Europe, with 
some 21% overall usage among women of reproductive age. In developing 
countries overall, the predominant methods are female sterilization and 
intrauterine devices (IUD). This is especially the case in Asia - in Africa and 
Latin America, for example, the contraceptive pill is more popular than IUD. 
Worldwide, IUD is used by approximately 14% of women aged 15-49 years 
and living in a relationship. Contraceptive pill is the third most used method 
with a 9% overall share and the widest geographical distribution.59,60  Soini et 
al. estimated in their study on cancer risk in women using the levonorgestrel-
releasing intrauterine system that up to 15% of fertile women used the system 
in Finland during their study period of 1994-200761. 
Regardless of extensive research, the scientific community still does not 
fully agree on the role of exogenous hormones in the etiology of breast 
cancer.  A large prospective cohort study on the association of oral 
contraceptive use and breast cancer risk observed a positive association, as 
did a recent meta-analysis and a hospital-based  case-control study62–64.  
Another population-based case-control study as well as a larger prospective 
cohort study found, however, no evidence of an association65,66.  Studies 
regarding the use of hormone-releasing intrauterine device (HR IUD) and 
breast cancer risk are more infrequent. A few studies have observed a 
significant increase in breast cancer risk among HR IUD users61,67,68 . There 
are, however, also studies where the association has not been observed, 
specifically in younger women69,70.  
According to the IARC, combined estrogen-progestogen contraceptives 
are carcinogenic to humans (Group 1 in overall evaluation). In the 
monograph, these substances were determined to cause cancer of the breast, 
in situ and invasive cancer of the uterine cervix, and cancer of the liver. 
Inverse associations are convincingly reported with respect to cancers of the 
endometrium, ovary, and colorectum.71 Regarding the use of progestogen-
only contraceptives, the previous IARC monograph was published in 1999 
and stated that there was inadequate evidence for a relationship between 
progestogen-only contraceptives and breast cancer72.  
According to the estimation of the European Commission, some 60% of 
women and 5-10% of men in Europe use hair dyes on average 6 to 8 times 
per year73. The history of hair dye use dates back to ancient Egypt, and today 
there are millions of people using cosmetic dyes74. Before the 1980s, hair 
dyes contained  aromatic amines, such as  4-methoxy-m-phenylenediamine 
(4-MMPD, 2,4-diaminoanisole), which was later found to cause cancer in 
animals75. In some studies, use of such hair dyes was connected to increased 
cancer risk also in humans76. As a result, manufacturers changed the 
formulation of hair dyes to remove some of these chemicals77. Currently, P-
phenylenediamine (PPD) is one of the most commonly used hair dye 
compounds. Its reactivity with air was discovered already in the 1860s and 
this was considered the starting point for development of synthetic, 
commercial hair dyes.78  Also the safety of PPD has been questioned, either 
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through its own properties or as a mediator for such known carcinogens as 4-
aminobiphenyl (4-ABP)79.  
Hair dyes can be divided into three basic groups by their mode of action. 
Permanent colors are oxidative and consist of colorless dye intermediates 
and dye “couplers”, which, in the presence of hydrogen peroxide, react with 
one another to form pigment molecules. These types of dyes are the most 
commonly used. Semi-permanent and temporary dyes are non-oxidative; 
they contain colored compounds that stain hair directly. Nowadays, however, 
also some semi-permanent dyes contain an oxidative agent80. 
Research on the association between hair dye use and risk of breast 
cancer has been relatively modest and the results somewhat contradictory. 
The studies of Nasca, Cook, and Petro-Nustas81–83 observed positive 
associations between hair dye use and breast cancer risk, whereas the studies 
of Zheng, Mendelsohn, Green, and Koenig84–87 found no evidence of an 
association. A Nordic study on the occupational cancer risks (NOCCA) 
reported a 6% increased risk of breast cancer for a cohort of female 
hairdressers relative to the population overall88. The previous IARC 
monograph on some aromatic amines, organic dyes, and related exposures 
from 2010 concluded that there was inadequate evidence for carcinogenicity 
of personal hair dye use and limited evidence in experimental animals for 
carcinogenicity of hair colorants, placing it in Group 3 in the overall 
evaluation (“Not classifiable as to its carcinogenicity to humans”) 89. 
6.5.2 USE OF OPPORTUNISTIC MAMMOGRAPHY - A FORM OF 
MEDICALIZATION? 
Maturo describes medicalization as a “process by which some aspects of 
human life come to be considered as medical problems, whereas before they 
were not considered pathological.”90 Bell sees medicalization as a modern 
process and concept that is increasingly often perceived also as a 
patient/consumer-driven phenomenon and not alone boosted by medical 
authorities or the pharmaceutical industry91. Opportunistic mammography is 
an example of physician-initiated as well as consumer-initiated use of 
medicine, often unnecessarily. Easy access to mammography fulfills both a 
woman’s willingness to obtain certainty of healthiness and a physician’s need 
to confirm or reject a diagnosis.  
As stated by Ouedraogo et al., organized breast cancer screening 
programs often coexist with easy access to opportunistic mammography in 
many developed countries. They define opportunistic mammography as a 
screening mammography performed based on a woman’s own initiative or 
following the advice of their physician. The system  of opportunistic 
mammography is considered as decentralized and lacking systematic and 
reliable reporting, making the evaluation of its effectiveness difficult.92 
One of the main principles of cancer screenings is that the benefits must 
override the potential harms resulting from the screening procedure, e.g. 
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excess radiation or unnecessary invasive diagnostic procedures resulting 
from a false-positive result or harmless benign change. The fulfillment of this 
principle is well-studied and confirmed for population-based organized 
screening programs, but wild, opportunistic screenings bring an unknown 
element to the equation. Regarding breast cancer, a high prevalence of 
mammography outside the organized screening program may distort the 
balance of benefits and harms, as we may unnecessarily screen women too 
much with the coexisting, overlapping systems of organized and 
opportunistic screening. 
 
 
Figure 5.   Breast cancer incidence in Finland in 1980 and 2009, rate per 100 000 persons.  
The major change in the pattern of breast cancer incidence over the past 
decades can be seen in Figure 5, which presents breast cancer incidence in 
Finland in 1980 and 2009. The incidence curve in 1980 show a relatively 
gradual increase in breast cancer incidence by age, whereas the 2009 curve 
shows a peak in the incidence at age 65 years and thereafter a downward 
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trend. Also, compared with the 1980 curve, the 2009 curve shows a steeper 
increase in the incidence from age 40 years, which may be related to a high 
number of mammography examinations already before the start of the 
organized screenings at the age of 50 years.  Significantly higher breast 
cancer incidence of younger women in 2009 compared to that of 1980 is 
mostly a result of organized mammography screening started in 1987. 
Compared to clinical screening, invitation-based screening detects cancers 
earlier, with respect to both stage and age. Without the invited screening, it 
might have taken several more years for the cancer to become symptomatic.  
6.5.3 STRESSFUL LIFE EVENTS  
Major stressful life events have been shown to increase the risk of depression 
and anxiety 93–95. In the Global Burden of Disease study in 2010, depression 
and anxiety disorders together accounted for over 50% of the overall disease 
burden measured in disability-adjusted life-years (DALYs)96.  
Brown & Harris carried out a classic study on the association between 
social and cultural factors and the onset of depression in women. They 
identified three major factors with an impact on the development of 
depression, with stressful life events,  such as loss of mother, lack of a 
confiding relationship, and unemployment, being one of them.97  
Depression and anxiety have subsequently been shown to be associated 
with greater mortality in cancer patients. A meta-analysis by Pinquart et al. 
concluded this to apply to women expressing depressive symptoms either 
before or after cancer diagnosis98. Satin and colleagues reached similar 
conclusions, estimating cancer mortality to be up to 39% higher in patients 
diagnosed with minor or major depression99. There are, however, also studies 
with contradictory results100. Psychological distress, including anxiety, was 
observed to be a predictor of cancer mortality overall101, and anxiety was also 
found to increase breast cancer-specific mortality102. One meta-analysis 
reported stressful life experiences to be associated with poorer all-cancer 
survival, and likewise, higher mortality. Site-specific analyses suggested that 
some psychosocial factors, such as depression, were also associated with 
poorer survival of breast cancer patients.103 By contrast, however, Maunsell 
and colleagues did not find evidence of an association between stressful life 
events and breast cancer-specific or all-cause mortality104.  
Studies on the impact of positively experienced life events on breast 
cancer survival or breast cancer-specific mortality are few. Both Levy and 
Tominaga reported perceived joy and positive life events to be associated 
with longer survival or decreased breast cancer mortality105,106. While Levy et 
al. found psychological expression of joy to be associated with longer survival 
with recurrent breast cancer, Tominaga and colleagues observed that having 
female children and hobbies affected the duration of survival in surgically 
treated breast cancer patients. 
  
29 
6.6 HISTORICAL TRENDS OF RISK FACTOR 
PREVALENCE 
The surrounding society is changing at an accelerating pace. The prevalences 
of such relatively contemporary exposures as hair dyes and hormonal 
contraceptives are at markedly different levels today than they were a few 
decades ago.  Accordingly, organized breast cancer screenings were initiated 
only in the 1980s, before which all mammograms were opportunistic, based 
either on symptoms or on a simple desire for reassurance of healthiness.  
These factors have considerably changed women’s lifestyle and behavior and, 
at the same time, significantly altered the risk factor spectrum and risk 
burden in terms of breast cancer. Some historical perspectives regarding the 
exposures of interest of this study are summarized in Figure 6.  
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Figure 6.  Historical turning points for the assessed life style factors related to breast cancer. 
Sources:  
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Hormonal contraceptives 1950 
● The first combined 
oral contraceptive pill 
was introduced in 1957.I 
● The first progestogen-
only contraceptive was 
introduced in 1969.II 
1980 
● The first HR IUD was 
developed in 1976. 
Wide-spread popularity 
was achieved along with 
the introduction of long-
acting devices  in 1990.III 
2014 
● Use of any modern 
contraceptive: 
Northern Europe: 1980: 
64.7%, 2014: 73.9% 
Eastern Africa: 1980: 
2.7%  2014: 35.5%IV 
Hair dyes 1950 
● First home color 
product launced in 
1947.V 
1980 
● FDA published a 
regulation requiring a 
special warning for all 
hair dye products 
containing two common 
dye ingredients as they 
were found to cause 
cancer in animals.VI  
2014 
● Some 60% of women 
and 5–10% of men in 
Europe use hair dyes on 
average six to eight 
times per year. VII 
Mammography 1950 
● Developed by Robert 
Egan in the late 1950's. 
Spread in clinical use 
after the mid 1960's.VIII 
1980 
● Breast cancer 
screening by 
mammography initiated 
in Finland nation-widely 
in 1987. 
2014 
● Screening 
participation rate 85% 
and some 1/3 of 
incident breast cancers 
detected in screening. 
Experienced stress 1950 
● "The father" of the 
current concept of 
stress Hans Selye 
published  "The stress of 
life" in 1956.IX 
1980 
● Brown & Harris  
(1978) carried out a 
classic study on the 
association of social and 
cultural factors and the 
onset of depression in 
women. X 
2014 
● The number of 
women feeling stressed 
is increasing. 22% 
reported being stressed 
in the AVTK 2014 
survey, the proportion 
in 1985-86 being13%. 
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The prevalence of many known risk factors of breast cancer has increased 
tremendously over the past decades, shaping the landscape of breast cancer 
epidemiology. Table 3 presents estimated changes in the prevalence trends of 
certain risk factors from the mid-1900s to 2000s.  
 
Table 3. Trends in the prevalence of breast cancer risk factors from the mid-1900s to 2000s. 
 
Also the educational structure of the population has changed markedly in 
the recent decades. The proportion of highly educated women has increased, 
while the proportion of women with only basic education has majorly 
decreased. Figure 7 illustrates the changes in the educational level of women 
over 15 years old in Finland in 1970-2015. 
 
Risk factor Prevalence trend   
Young age at menarche ↑ 
Nulliparity ↑ 
Small number of full-term pregnancies ↑ 
High age at first birth ↑ 
Breastfeeding  ↑ 
Earlier age at menopause ↑ 
Ever use of combined oral contraceptives ↑ 
Ever use of intrauterine device ↑ 
Ever use of hormonal therapy for menopause ↓ 
Ever use of alcohol ↑ 
Obesity, BMI ≥30 kg/m2 ↑ 
Physical inactivity ↑ 
Amount of ionizing radiation from medical sources ↑ 
Opportunistic mammography ↑ 
Experienced stress ↑ 
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Figure 7.  The percentages of women over 15 years old in Finland by educational level in 
1970-2015. 
Age at menarche has been shown to become lower since the start of 
industrialization, initially due to improved health and nutrition and later at 
least partly due to increasing number of overweight children115,116. In most 
developed countries, the decline in age at menarche has today somewhat 
levelled off117. There have also been suggestions that age at menopause in 
Europe may be shifting towards higher ages, although prevalence of many 
factors presumed to affect early menopause, such as smoking, nulliparity, 
and overweight, have become more common118,119.  In an American study, a 
17-month increase in the mean age at menopause was observed for women 
born between 1915 and 1939 (49.1 vs. 50.5 years), after adjusting for 
potential confounders120. 
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Many factors related to reproduction have also gone through major 
changes. The proportion of nulliparous women in Finland has increased over 
the past two decades.  According to Official Statistics Finland (OSF), 13.8% of 
Finnish- or Swedish-speaking women aged 45-49 years were nulliparous in 
1990, the corresponding percentage in 2014 being 18.7%. Parity has 
decreased most among women in the lowest educational class; 22% of 45 to 
49-year-old women with only basic education were nulliparous in 2014, 
compared with 12% in 1990. Parity among highly educated women has in 
turn remained nearly the same, with 18.6% of women aged 45-49 years being 
nulliparous in 1990 and 18.9% in 2014.121  
Also the number of children in families has decreased. While the total 
fertility rate in Finland in 1950 was 3.16, in 2014 it was 1.71, according to 
Statistics Finland. Even though there is still some post-war effect seen in the 
1950 figure, the trend overall has been declining since 1910122. With respect 
to age at first birth, the average age at first delivery among women born in 
the 1950s was 25 years. Women born in the 1980s, by contrast, gave birth to 
their first child around the age of 30 years.123 The trend, however, seems to 
have plateaued in recent years122.   
As for breastfeeding, there was a marked downward trend from the 1930s 
to the 1970s in the proportion of children breastfed for at least 6 months. 
Since then, the trend has been upwards, the respective percentage being 60% 
in 2005.  Still, exclusive breastfeeding until the age of 6 months is very rare 
in Finland, around 1%, compared with e.g. Sweden, where about 15% of 
babies are exclusively breastfed until 6 months of age.124 Overall, 
breastfeeding is more prevalent in poor than rich countries. While the 
prevalence of breastfeeding for at least 12 months is below 20% in most high-
income countries, it is close to 100% in many African countries, South Asia, 
and parts of Latin America.125 
As a result of the altered reproduction behavior and modern innovations, 
contraceptive patterns have also changed significantly over the past 50 years. 
The first combined oral contraceptive pill was introduced in 1957 and the 
first progestogen-only contraceptive in 1969, and according to the IARC, 
there were approximately 100 million women worldwide in the year 2000 
using combined hormonal contraceptives126. The shift from traditional to 
modern contraceptive methods has been vast. 
Use of hormone therapy for menopausal symptoms increased 
tremendously since the introduction of the first preparations in the 1940s, 
but the usage has been declining since studies such as the Women’s Health 
Initiative in 2002, convincingly showing their adverse effects with respect to 
the risk of breast cancer and some other diseases. The peak usage was in 
1999, when some 20 million women in developed countries used combined 
hormonal therapy. Since 2002, the use has declined by more than 50%.35  
The use of radiation in medical applications has increased markedly, 
especially in industrialized countries in the recent decades. Radiation in 
medicine accounts for some 98% of all ionizing radiation exposure obtained 
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from artificial sources, and it is responsible for nearly 20% of the total 
burden of ionizing radiation. In developed countries, where the vast majority, 
about two-thirds, of all radiological operations occurs, up to 50% of the 
annual average effective dose of ionizing radiation comes from medical use. 
Continuing modernization will lead to further increases in population doses 
of ionizing radiation due to medical exposure. According to UNSCEAR 
(United Nations Scientific Committee on the Effects of Atomic Radiation), 
the annual number of medical radiological operations worldwide was some 
3.6 billion in 1997-2007, while the corresponding figure in 1991-1996 was 2.5 
billion.127 It was also reported that there were ca. 38 X-ray generated 
mammography equipment per 1 million population in Finland in 2008. The 
corresponding number in e.g. Sweden and Australia was 20 per 1 million 
population. France, Germany, and Greece held the top positions with 
Finland, all with some 40 equipment per 1 million population.  
As shown by the Health Behaviour and Health among the Finnish Adult 
Population (AVTK) survey, the proportion of Finnish women reporting 
themselves as being stressed has been increasing over the past decades. In 
1978-1982, on average 13% of women reported experiencing stress, the 
corresponding percentage in the 2009-survey being 20% and in 2014-survey 
about 22%128. Accordingly, while 17% of respondents reported depressive 
symptoms in the past month in the 1985-1986 survey, 20% reported the 
same in the 1998-1999 survey129.  
Women’s alcohol use in Finland has been increasing since the 1960s, 
relatively more than men’s. In 1968, some 40% of women reported never 
using alcohol, while at the beginning of the 2000s about 90% of women 
reported using alcohol within the last 12 months.  Women are also 
consuming an increasingly large proportion, 25%, of all alcohol consumed in 
Finland. In 1968, women accounted for approximately 10% of the total 
consumption.130,131   
In 2012, 77% of Finnish women aged 25-64 years reported being 
physically active during their leisure time, and correspondingly, 18% 
reported being physically active while commuting. Leisure-time activity has 
increased over the past four decades; the increase has, however, levelled off 
since its peak in the 1970s and 1980s. Physical activity while commuting has 
decreased until 1992, after which it has remained more or less constant. 
Physical activity or strain at work has accordingly decreased steadily since 
the 1970s, in part contributing to the decrease in overall activity of the 
population.132   The BMI of Finnish women has increased since the 1980s, 
currently, however, at a plateau. In 2012, around 46% of Finnish women 
were overweight and 19% obese. Although the proportion of overweight 
women is no longer increasing (at least not greatly), the proportion of obese 
(BMI: ≥30 kg/m2) women continue to rise.133   
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7 AIMS OF THE STUDY 
The main aim of this study was to empirically evaluate the roles of currently 
common but controversial factors that are highly dependent on culturally 
related behavior and potentially impact breast cancer outcomes. The aim was 
also to gain an overall view of the etiology of breast cancer in modern 
Western society from an epidemiological perspective, considering also 
changes over time.   
 
7.1 SPECIFIC AIMS 
Regarding breast cancer risk factors, studies examining the roles of hormonal 
contraceptive use and hair dye use in the etiology of breast cancer were 
carried out.  
The proportion of women who had an opportunistic mammography 
before the age of 50 years was estimated and the roles of breast cancer family 
history and educational level in having an opportunistic mammography were 
also assessed.  
Finally, the impact of pre- and post-diagnostic negatively or positively 
experienced major life events in breast cancer-specific mortality was 
investigated.  
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8 MATERIAL AND METHODS 
8.1 CANCER INFORMATION 
Information on the outcomes of interest, namely breast cancer diagnosis and 
breast cancer-specific deaths, was retrieved from the FCR. The FCR is a 
population-based, nationwide registry that covers about 99% of solid 
tumors134. Nationwide cancer registration was started in Finland in 1953, and 
with unique personal identity numbers and regular linkages and updates for 
deaths and immigration, there are basically no losses to follow-up. 
Information on causes of death is updated to the FCR from Statistics Finland 
annually, information on immigration is obtained from the Population 
Registry Centre (PRC). Data used in the studies include details on 
topography, histology, morphology, and cancer stage, as well as the primary 
cause of death.  Breast cancer was defined as the person’s first in situ or 
invasive breast cancer registered at the FCR at the end of 2008. All 
morphologies of breast cancer were included.  
8.2 WOMEN’S HEALTH AND USE OF HORMONES 
(WHH) SURVEY  
The primary source of exposure information was the survey “Women’s 
Health and Use of Hormones” (WHH), conducted in 2009 (Figure 8). The 
WHH survey was initially developed to address the association between use 
of hormones and risk of breast cancer69. Additionally, the survey mapped out 
several other known or suspected factors impacting the risk of breast cancer 
or survival from it, such as family history of breast cancer, age at menarche, 
smoking, alcohol use, BMI, physical activity, use of hair dyes, 
mammography, and stressful life events.  
The survey was aimed at women diagnosed with breast cancer in Finland 
in 2000-2007 and aged 18-60 years at diagnosis. The survey was mailed to 
study subjects and it was self-administered and identical for cases and 
controls. The filled and returned survey was considered as an informed 
written consent. Breast cancer cases were identified from the FCR in 
December 2008. Age-matched controls were randomly sampled from the 
PRC.  
Initially, 14 815 women with breast cancer were considered eligible for the 
survey. After excluding women who had died or emigrated, who had had a 
previous malignancy, or who had been erroneously sampled, 9 537 cancer 
cases remained, 6 567 (67%) of whom responded to the questionnaire. After 
two rounds of control samplings, 41 978 control women remained in the 
sample, out of the 64 353 originally identified. Of these, 23 114 responded to 
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the survey (55%).  After excluding controls reporting previous malignancies 
(N=1 516), 21 598 controls were left in the analytical data set.  
 
  
39 
 Fi
gu
re
 8
.  
Fl
ow
ch
ar
t o
f t
he
 n
um
be
r o
f s
tu
dy
 s
ub
je
ct
s 
fro
m
 id
en
tif
ic
at
io
n 
to
 th
e 
st
at
is
tic
al
 a
na
ly
si
s 
of
 th
e 
W
H
H
 
da
ta
 (W
om
en
’s 
He
alt
h a
nd
 U
se
 of
 H
orm
on
es
) a
nd
 th
e 
da
ta
 s
ou
rc
es
 a
nd
 n
um
be
rs
 o
f s
tu
dy
 s
ub
je
ct
s 
in
 e
ac
h 
su
b 
st
ud
y.
 D
at
a 
fro
m
 th
e 
W
H
H
 in
 b
lu
e 
an
d 
fro
m
 th
e 
E
E
T 
in
 re
d.
 
 40 
8.3 BREAST CANCER SCREENING, LIFESTYLE AND 
QUALITY OF LIFE (EET) SURVEY 
In Study III, the survey ”Breast Cancer Screening, Lifestyle and Quality of 
Life” (EET) was also utilized  for information on opportunistic 
mammography. In 2012 and 2013, the EET survey was sent to 5 000 women 
born in 1963 and 1964, respectively (a total of 10 000 women aged 49 years 
at survey), randomly sampled from the PRC. In addition to the questions on 
lifestyle and quality of life, the EET surveys covered information on the 
family history of breast cancer, education, and opportunistic mammography. 
Any mammography was considered opportunistic, as the respondents were 
still below the age of organized screening, which starts at the age of 50 years.  
 
8.4 EXPOSURES IN SUB STUDIES 
Questions on hormonal contraception use were covered in the WHH survey. 
The use of HR IUD was asked as never- vs. ever-use. Use of other hormonal 
contraceptives (oral contraceptive pills, contraceptive patches, contraceptive 
implant, or contraceptive injection) was defined as never- vs. ever-use and 
the total duration of use was also queried.  
Hair dye use as an exposure was defined as personal hair dye use reported 
in the WHH survey. The different dye types were defined as follows:  
‘Temporary’ = a color that rinses off at first wash, ‘Semi-permanent’ = a color 
that rinses off after several washes, ‘Permanent’ = a color that does not wash 
off, ‘Bleach’ = hair was bleached before coloring, and ‘Partial’ = hair was only 
partially dyed. The frequency of dye episodes in each of the above-mentioned 
categories was classified as ‘Often’, ‘Quite often’, ‘Rarely’, or ‘Never’. The 
responders were also asked to estimate the cumulative number of hair dye 
episodes during life as well as the age at first dye.  
Opportunistic mammography in Study III was defined as mammography 
examinations carried out before the national screening-age of 50 years. In 
the WHH survey, the responders was asked whether she had had a 
mammography and to specify the age at first mammography. In the EET 
survey, the responder was simply asked whether she had ever had a 
mammography. In both surveys, mammography may refer to either purely 
opportunistic, self-initiated mammography executed for reassurance of one’s 
healthiness in the private sector or symptom-induced, physician-initiated 
mammography in private or public health-care. Family history of breast 
cancer was used as either the primary exposure or it was treated as a 
confounding variable in the statistical analyses. A person was considered to 
have a family history of breast cancer if she had reported at least one first-
degree relative being affected with breast cancer.  
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In the WHH survey, the responders were given a list of 22 negative and 8 
positive life events and were asked to indicate if the specific event had been 
experienced and if so, when. The responders were also asked to rate the 
experienced negative event according to its perceived impact as “Not very 
hard”,” Hard” or “Extremely hard”.  
Level of education was considered in all sub studies. Information on the 
educational level of the WHH survey responders in Studies I, II, and III was 
based on self-reporting, in Study IV, the educational level was obtained from 
Statistics Finland. Educational level of the EET survey responders utilized in 
Study III was also retrieved from Statistics Finland. Educational categories in 
the studies were based on the number of school years; women with a 
maximum of 12 years of education falling into the category of low education 
and those with more than 12 years of education categorized as having high 
education.  
8.5 STUDY POPULATIONS AND DATA COLLECTION 
PROCESSES 
Study I on the relationship between hormone use and breast cancer risk 
utilized the WHH survey as the source of information on exposures and the 
FCR as the source of data on the cancer outcomes. Additionally, aggregated 
data from the OSF and from two Finnish nationwide surveys; the Health 
Behavior and Health among the Finnish Adult Population in 2010 (AVTK,  
1 583 female responders) and the national FINRISK study from 2007 (3 346 
female responders) were used for data validation. For comparability with the 
referent surveys, WHH responders born before 1 945 (640 cases, 1965 
controls) were omitted from the study to have equal age cohorts in all 
surveys. 
The source of exposure data in Study II, which examined the effects of 
hair dye use, was the WHH survey with 6 567 cases and 21 598 controls aged 
22-60 years. Information on the cancers was retrieved from the FCR. 
Study III on the use of opportunistic mammography utilized both the 
WHH survey and the EET survey as data sources and included 9 845 women 
without cancer in total. From the WHH survey, breast cancer cases were not 
included in the analysis, but controls aged 45-49 years at the time of the 
survey formed the analytical dataset (N= 4 666). From the EET survey, 5 179 
women aged 49 years were included in the analysis. 
Study IV on the impact of major life events utilized WHH survey data 
from the responded breast cancer cases as the source of exposure 
information. As matching with the control population was not needed, all 
responding breast cancer cases could be included in the analysis (N=8 364). 
Outcome data (death due to breast cancer) were retrieved from the FCR. 
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8.6 VALIDATION AND STATISTICAL METHODS 
Validity assessment of the WHH survey data was also conducted. The 
exposure prevalences retrieved from the WHH survey were compared with 
corresponding data from OSF as well as AVTK and FINRISK-studies with 
simple cross-tabulation and by estimating the differences in prevalences in 
percentage points. Data from OSF were available regarding education, parity, 
and marital status. Additionally, AVTK and FINRISK -studies provided 
information on alcohol use, smoking, BMI, and use of hormonal 
contraceptives, including HR IUD. 
The AVTK and FINRISK studies by the National Institute of Health and 
Welfare were used as reference data because of their established nature as 
routine nationwide health surveys and because they have been validated and 
conform to the guidelines of the European Health Risk Monitoring project. 
The OSF, in turn, offers statistical aggregation of authority-based data, 
providing virtually complete data on the variables of interest. 
Study I utilized conditional logistic regression to estimate odds ratios 
(ORs) and 95% confidence intervals (CIs). The obtained results were 
compared with those reported in earlier large-scale studies on breast cancer 
risk factors. Analyses were stratified by age: women aged 50 years or less at 
survey and those aged 51 years or over. Univariate results were adjusted for 
birth year; multivariate analysis included the following covariates: use of HR 
IUD, use of other hormonal contraceptives, use of hormone replacement 
therapy, age at menarche, parity, family history of breast cancer, BMI, 
education, smoking, and alcohol use. 
In Study II, ORs, with 95% CIs were reported from the conditional logistic 
regression model applied to a frequency-matched study design. Potential 
confounding factors, such as parity and family history of breast cancer, were 
included in the multivariate adjusted model, as suggested by the step wise 
model search. Dose-response trend according to the number of hair dye 
episodes and the odds of breast cancer was tested by treating the number of 
episodes as a continuous variable in the logistic regression. The attributable 
fraction in exposed subjects was calculated with the formula ((OR-1)/OR) x 
100. This represents the magnitude of the role of hair dye use in breast 
cancer risk in the exposed subjects.  
Due to study populations of different ages and with different types of 
variable categorization, the percentages of women having had at least one 
mammography before the age of 50 years were estimated differently from the 
WHH and EET surveys. From the WHH survey, the percentages were 
estimated by the Kaplan-Meier method, as there were several categories 
given for the age at first mammography. From the EET, all reported 
mammographies were considered opportunistic as all respondents were 
under 50 years of age, and the percentages could be directly drawn from 
these figures. Ratios of percentages for opportunistic mammography in 
women with or without family history of breast cancer and with different 
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levels of education were estimated by Poisson regression with log-link 
function and profile likelihood based on 95% confidence intervals. 
Regarding the primary exposures in Study IV, each negative life event was 
given a score (0-3) based on the reported impact of the event; score 0 was 
given if the person had not reported the event. Total stress score of the 
negative life events was formed by adding all event-specific scores together, 
the total stress score ranging from 0-66. Information on the experienced 
impact with respect to positive life events was not asked in the survey, and 
these events were considered individually as such without impact weights.  
Different Cox models were used to estimate breast cancer-specific 
mortality hazard ratios (MRs) and their 95% confidence intervals for the 
different exposures. The patients were followed up until the end of 2013, the 
primary end point in all Cox models being death due to breast cancer. The 
observed survival times were effectively conditioned on surviving up to the 
survey, all estimated Cox models thus allowing for delayed entry. Age groups 
of 0-54, 55-59, and 60+ years were used in the analyses. Parity, BMI, alcohol 
use, physical activity, cancer stage, cancer type, and cancer behavior were 
included as controlling variables in all models. 
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9 RESULTS 
9.1 BASIC CHARACTERISTICS FROM THE WHH 
SURVEY 
With respect to morphology of the cancers of the WHH case-responders,  
5 248 (80%) were ductal carcinomas, 4 758 (91%) of which were invasive, 
whereas 1 022 (16%) were lobular carcinomas, 1 002 (98%) of which 
invasive. The remaining 4% (N= 297) included cases of medullary, mucinous, 
tubular, and other more infrequent types of breast cancer, or cases where 
morphology could not be clearly specified. These morphological distributions 
correspond to the estimated population-level figures7.  
Regarding the diagnostic ages of the cases who responded to the survey 
compared with those who did not, no major differences were observed, 
median age being 52 years in both responders and non-responders. Median 
age at the time of the survey was 57.5 years among both cases and controls. 
Cases had a response rate of 69% and controls 55%. With respect to different 
age groups, the response figures varied from 52% to 69%, being the lowest in 
controls aged 35-44 years (52%) and the highest in cases aged 35-44 years 
and 55-64 years (both 69%). 
  
9.2 PREVALENCE OF PRIMARY EXPOSURES  
The overall prevalences of the primary exposures are presented in Table 4.  
Exclusive ever-use of HR IUD was reported by 7% of both breast cancer 
cases and controls aged 50 years or less. Of the responders aged 51 years or 
over, 15% of the cases reported exclusive ever-use of HR IUD, whereas only 
1% of the controls reported the same. With respect to use of other hormonal 
contraceptives, 89% of the breast cancer cases aged ≤ 50 years reported ever-
usage, compared with 86% of same-aged controls. Within the age group of ≥ 
51 years, 72% of cases reported ever using other hormonal contraceptives, the 
corresponding figure among the controls being 71%. 
The prevalence of hair dye use varied over time. While 84% of the WHH - 
responders born before 1950 reported ever using hair dyes, of the women 
born in or after 1960 already 92% reported ever-use.  Some 19% (4 752 of the 
total of 24 479) of the ever-users of hair dye reported using dyes 90 times or 
more in their life time. Regarding differences between breast cancer cases 
and controls, ever-use of hair dyes was slightly more common among cases, 
with 88.2% of cases reporting ever-use vs. 86.5% of controls. No difference 
emerged in age at first dye between cases and controls, 62% of women 
reporting the first dye episode at an age of less than 30 years.  
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The most commonly reported negative pre-diagnostic life events in the 
WHH survey were death of a parent or other close relative, divorce or 
separation, serious illness of a family member, miscarriage, and financial 
difficulties. Of the events occurring post-diagnostically, illness causing work 
disablement, death of a close relative, serious illness of a family member, 
retirement, death of a close friend, and relationship problems with spouse 
were most often encountered.  With respect to positive life events, falling in 
love and positive developments in living conditions and in family 
relationships were the most common pre-diagnostically experienced events. 
Post-diagnostically, positive developments in family or personal 
relationships and in hobbies were most commonly reported. 
Overall, some 13% of responders in the WHH survey reported having a 
family history of breast cancer. Of the breast cancer cases, 17% reportedly 
had at least one first-degree relative affected with breast cancer, and as for 
the controls, the figure was 9%. In the EET survey, the corresponding 
percentage among women without cancer was 10%.  
Regarding the level of education, 49% of the women in the WHH survey 
reported a higher level of education (> 12 years). The corresponding figure in 
the EET survey, where the information was retrieved from Statistics Finland, 
was 55%. These figures concern women aged less than 50 years at the time of 
the survey. The proportion of highly educated women was lower among the 
older responders; some 35% of the WHH-responders aged more than 50 
years had a high education.   
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Table 4. Prevalence of primary exposures in each sub study 
 
Exposure 
% of 
respondent cases 
in the WHH 
% of respondent 
controls in the WHH 
% of 
respondents in the 
EET 
Use of hormonal intrauterine 
device (Study I) 
   
Ever 22 8 - 
Never 78 92 - 
Use of other hormonal 
contraceptives (Study I) 
   
Ever 75 74 - 
Never 24 25 - 
Hair dye use (Study II)    
Ever 88 87 - 
Never 12 14 - 
Pre-diagnostic negative life 
events1 (Study IV) 
 - - 
Death of a parent 39 
Death of  other close relative 16 
Divorce or separation 11 
Serious illness of a family member 10 
Miscarriage 8 
Financial problems 8 
Post-diagnostic negative life 
events (Study IV) 
 
Illness causing work disablement 27 
Death of a close relative 21 
Serious illness of a family member 17 
Retirement 16 
Death of a close friend  13 
Relationship problems with spouse 11 
Pre-diagnostic positive life 
events2 (Study IV) 
   
Falling in love 20   
Positive development in living 
conditions 
13   
Positive developments in family 
matters 
 
11   
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Table 4. Continued. 
Post-diagnostic positive life 
events (Study IV) 
   
Positive developments in family 
matters 
39   
Positive developments in 
personal relationships 
30   
Positive developments in 
hobbies 
29   
Family history of breast cancer3     
Yes 17 10 10 
No 83 88 90 
Level of education4    
≤12 years 61 63 45 
>12 years 38 36 55 
 
1Six most commonly reported life events listed.  
2Three most commonly reported life events listed. 
3Reportedly at least one first-degree relative affected with breast cancer, based on WHH results in Study I, EET 
results in Study III. 
4As self-reported in the WHH survey for Studies I, II and III, and from Statistics Finland for Study IV.  For the EET 
survey information retrieved from the Statistics Finland (Study III).  
 
9.3 RESULTS FROM STUDY I - HORMONE USE AND 
RISK OF BREAST CANCER 
Exclusive use of HR IUD was associated with increased breast cancer risk 
among post-menopausal women (OR 1.52, 95% CI: 1.14-2.02) when 
comparing ever-users with those using or having exclusively used a copper-
releasing intrauterine device. An effect of similar magnitude (OR 1.48, 95% 
CI: 1.10-1.99) was observed also when comparing  post-menopausal, 
exclusive HR IUD-users with never-users of any hormonal contraceptive and 
including only cases who reported using HR IUD before breast cancer 
diagnosis. 
As for use of other hormonal contraceptives, ever-usage increased breast 
cancer risk by 32% (OR 1.32, 95% CI: 1.08-1.61) in pre-menopausal women 
and by 8% (OR 1.08, 95% CI: 1.01-1.16) in post-menopausal women, 
compared with never-users of other hormonal contraceptives. When 
restricting the analysis to the more recently (2004-2007) diagnosed cases, 
we obtained an OR of 1.14 (95% CI: 1.02-1.29). By contrast, an OR of 0.91 
(95% CI:  0.80-1.03) was observed for those diagnosed in 2000-2001. 
Significant associations were also observed with respect to the duration of 
other hormonal contraceptives use in both pre- and post-menopausal women 
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(OR 1.37, 95% CI: 1.12-1.68 and OR 1.11, 95% CI: 1.03-1.20, respectively), 
when comparing usage of ≥ 2 years with never-users. 
9.4 RESULTS FROM STUDY II - HAIR DYE USE AND 
RISK OF BREAST CANCER 
When comparing ever-users of hair dyes with never-users, we observed a 
significant association with increased risk of breast cancer in the multivariate 
analysis including a set of confounders (OR 1.23, 95% CI: 1.11-1.36). 
Regarding different age groups, the odds of breast cancer were most 
increased in women born before 1950 (OR 1.28, 95% CI: 1.10-1.48, ever- vs. 
never-use of hair dyes). In comparison, an OR of 1.14 (0.85–1.54) was 
obtained for women born in 1960 or later. 
With respect to cumulative number of life time hair dye episodes, we 
obtained OR 1.07 (95% CI: 0.88-1.29) for 1-2 dye episodes in total and OR 
1.31 (95% CI: 1.14-1.51) for 35-89 dye episodes. A significant trend for dose-
response was also observed (P= 0.005).  
When estimating the role of age at first hair dye episode, a significant 
association between earlier starting age and breast cancer risk was observed 
(OR 1.14, 95% CI: 1.05-1.25) when comparing women reportedly starting to 
dye their hair at age 20-29 years with women starting at 40 years of age or 
later. It should be noted, however, that no association was seen when 
comparing women with first hair dye under the age of 20 years and those 
started at ≥ 40 years of age (OR 1.06, 95% CI: 0.96–1.16). With pooled age 
groups (first hair dye at age <30 years vs. ≥30 years), the odds of breast 
cancer was 1.07 (95% CI: 1.01-1.14) for women first using hair dyes before the 
age of 30 years. 
 
9.5 RESULTS FROM STUDY III - OPPORTUNISTIC 
MAMMOGRAPHY BEFORE ORGANIZED 
SCREENING 
Of the responders aged 45-49 years in the WHH survey, 66.7% had 
reportedly had their first mammography, the corresponding figure drawn 
from the EET survey being 60.4%. When comparing women with breast 
cancer family history with women without a family history of breast cancer, 
the percentage ratio (PR) for having an opportunistic mammography was 
1.06 (95% CI: 0.98-1.15), as estimated from the WHH survey, and 1.17 (95% 
CI: 1.09-1.26), as estimated from the EET data.  
Education of more than 12 years was associated with an increased 
proportion of opportunistic mammography, relative to schooling of 12 years 
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or less. PR for women with longer education from the WHH data was 1.05 
(95% CI: 1.00-1.10) and from the EET 1.17 (95% CI: 1.09-1.26).  
9.6 RESULTS FROM STUDY IV - MAJOR LIFE EVENTS 
AND BREAST CANCER-SPECIFIC MORTALITY 
Regarding the total stress score of the reported negative life events and their 
experienced impact, the average score was 14, with an observed range from 0 
to 51.  The 25%, 50%, and 75% quantiles were 9, 13, and 18, respectively. 
While there was no association between high total stress score from pre-
diagnostic negative life events and breast cancer-specific mortality, women 
with total stress score of 9-12 from post-diagnostic negative life events had 
significantly higher breast cancer-specific mortality (MR 1.81, 95% CI: 1.23-
2.67), when compared with women with a maximum score of 8. No 
relationship was observed with respect to the two highest total stress score 
groups (13-17 and 18-66). None of the individual pre-diagnostic negative life 
events was associated with breast cancer-specific mortality, while e.g. post-
diagnostic retirement (MR 1.87, 95% CI: 1.59-2.19), illness causing work 
disablement (MR 1.29, 95% CI: 1.16-1.44), and unemployment of spouse (MR 
1.28, 95% CI: 1.02-1.61) increased breast cancer-specific mortality. Positive 
associations were also observed with respect to post-diagnostic relationship 
problems with spouse (MR 1.23, 95% CI: 1.08-1.41) and death of a close 
friend (MR 1.19, 95% CI: 1.04-1.36).   
Out of the surveyed positive life events, falling in love and hobbies stood 
out in the analysis. Falling in love pre-diagnostically and post-diagnostic 
positive development in hobbies had a favorable impact on breast cancer-
specific mortality, decreasing mortality by 33% (MR 0.67, 95% CI: 0.49-
0.92) and 26% (MR 0.74, 95% CI: 0.57-0.96), respectively.     
Estimated attributable fractions of the use of HR IUD (calculated from 
OR 0.79, 95% CI: 0.54-1.17 and OR 1.48, 95% CI: 1.10-1.99, comparing 
exclusive users of HR IUD into never-users of any hormonal contraceptive) 
were -26.58 (95% CI: -85.19 – 14.53) for women in the age group 25-50 years 
and 32.43 (95% CI: 9.09 – 49.75) for women aged 51-64 years at survey. 
With respect to use of other hormonal contraceptives, the attributable 
fractions were calculated from the odds ratios comparing ever-users of other 
hormonal contraceptives to never-users (1.32, 95% CI: 1.08–1.61 in age 
group 25-50 years and 1.08, 95% CI: 1.01–1.16 in age group 51-64 years). The 
obtained attributable fraction in the younger age group was 24.24 (95% CI: 
7.41-37.89) and in the older age group 7.41 (95% CI: 0.99-13.79). Total stress 
score derived from the reported impact of negative life events that occurred 
before the breast cancer diagnosis did not appear to affect breast cancer-
specific mortality. In contrast, some 4% of the breast cancer deaths were 
estimated to be attributable to post-diagnostic negative life events (3.85, 95% 
CI: 0.99 – 6.54).  
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Measures of the associations between primary exposures and breast 
cancer outcomes as considered in the sub studies are presented in Table 5, 
and attributable fractions of hair dye use and IUD use in the risk of breast 
cancer and of life events in breast cancer-specific mortality are shown in 
Table 6. 
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Table 5.  Measures of the associations between primary exposures and the defined 
outcomes used in the sub-studies. 
Exposure/Association 
Effect 
estimate used 
WHH 
respondents 
EET 
respondents 
  Age at survey  
25-50 years 
Age at survey 
51-64 years 
 
Use of HR IUD  
Ever 
Never1a 
Use of other hormonal 
contraceptives 
 
Ever 
Never 
Odds ratio1b 
 
0.79 (0.54-1.17) 
1.0 
 
 
 
1.32 (1.08–1.61) 
1.0 
 
1.48 (1.10-1.99) 
1.0 
 
 
 
1.08 (1.01–1.16) 
1.0 
- 
Use of hair dyes 
 
 
Ever 
Never2a 
Odds ratio2b 
All respondents 
-  
1.23 (1.11-1.36) 
1.0 
Opportunistic mammography 
before organized screening 
Breast cancer family history  
Yes3a 
No 
 
Educational level, school years 
≤12 years 
>12 years 
Percentage 
ratio3b 
Age at survey < 50 years 
 
 
 
1.17(1.09-1.26) 
1.0 
 
 
1.0 
1.17 (1.09-1.26) 
 
1.06(0.98-1.15) 
1.0 
 
 
1.0 
1.05 (1.00-1.10) 
Major life events and breast 
cancer mortality 
 
 
 
P
re
-d
ia
gn
os
tic
 li
fe
 e
ve
nt
s 
 
Total stress score4a 
Death of father 
Death of mother 
Death of  other close 
relative 
Divorce or separation 
Serious illness of a 
family member 
Miscarriage 
Financial problems 
Mortality 
hazard ratio4b 
1.00(0.97-1.02) 
1.07(0.93-1.22) 
1.11(0.98-1.26) 
1.03(0.88-1.21) 
 
1.13(0.99-1.30) 
1.02(0.88-1.18) 
 
1.10(0.93-1.31) 
0.96(0.80-1.14) 
- 
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Table 5. Continued.  
P
os
t-d
ia
gn
os
tic
 li
fe
 e
ve
nt
s 
 
Total stress score4a 
Illness causing work  
disablement 
Death of other close 
relative 
Serious illness of a family 
member 
Retirement 
Death of a close 
friend  
Relationship 
problems with spouse 
1.04(1.01-1.07) 
1.29(1.16-1.44) 
 
0.94(0.81-1.09) 
 
1.05(0.93-1.19) 
 
1.87(1.59-2.19) 
1.19(1.04-1.36) 
 
1.23(1.08-1.41) 
 
P
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(p
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) i
n 
Family  
Work 
Personal 
relationships 
Spiritual life 
Financial situation 
Living conditions 
Hobbies 
Falling in love 
0.89(0.60-1.33) 
0.83(0.55-1.26) 
0.85(0.57-1.28) 
 
0.71(0.40-1.25) 
0.74(0.47-1.16) 
0.92(0.65-1.30) 
0.90(0.58-1.39) 
0.67(0.49-0.92) 
P
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(p
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tic
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) i
n 
Family  
Work 
Personal 
relationships 
Spiritual life 
Financial situation 
Living conditions 
Hobbies 
Falling in love 
0.85(0.62-1.17) 
0.96(0.73-1.26) 
1.09(0.83-1.44) 
 
1.22(0.89-1.67) 
0.94(0.73-1.22) 
0.88(0.65-1.19) 
0.74(0.57-0.96) 
1.01(0.69-1.47) 
 
1a Never-users of any hormonal contraceptive,1bOdds ratios with 95% confidence interval, multivariate model 
adjusted for either HC or HR IUD use, education, family history of breast cancer, age at menarche, parity, body 
mass index, smoking and alcohol use, 2aReported never using hair dyes,2bOdds ratios with 95% confidence interval, 
multivariate model adjusted for birth year, parity, age at first birth, family history of breast cancer, menarche age, 
use of hormonal contraceptives, physical activity, alcohol use, body mass index and level of education, 3aReported 
at least one first degree relative affected with breast cancer,3bUnivariate ratios of percentages with 95% confidence 
interval,  4a Total stress score as a continuous variable, 4bBreast cancer-specific mortality ratio from a multivariate 
model, adjusted for parity, body mass index, alcohol use, physical activity, cancer stage, cancer type, and cancer 
behavior. 
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Table 6. Attributable fractions of hair dye use and use of hormonal contraceptives in the risk of 
breast cancer and of life events in breast cancer-specific mortality. 
Exposure 
OR (95% CI) from which 
calculated 
Attributable fraction % 
(95% CI) in breast cancer 
risk 
Use of HR IUD, age group 25-50 0.79 (0.54-1.17) -26,58 (-85,19-14,53) 
Use of HR IUD, age group 51-64 1.48 (1.10-1.99) 32,43 (9,09-49,75) 
Use of other HC, age group 25-50 1.32 (1.08–1.61) 24,24 (7,41-37,89) 
Use of other HC, age group 51-64 1.08 (1.01–1.16) 7,41 (0,99-13,79) 
Use of hair dyes 1.23 (1.11–1.36) 18,70 (9,91-26,47) 
 MR (95% CI) from which 
calculated 
Attributable fraction in 
breast cancer-specific 
mortality (95% CI) 
Pre-diagnostic negative life events 1.00 (0.97-1.02) 0 (-3,09 – 1,96) 
Post-diagnostic negative life 
events 
1.04 (1.01-1.07) 3,85 (0,99 – 6,54) 
Pre-diagnostic falling in love 0.67 (0.49-0.92) -49,25 (-104,08 - -8,70) 
Post-diagnostic hobbies 0.74 (0.57-0.96) -35,14 (-75,44 - -4,17) 
 
9.7 RESULTS FROM VALIDITY ASSESSMENT 
Compared with AVTK, FINRISK, and OSF, the WHH survey responders were 
more often highly educated and parous, and this effect was more pronounced 
in the younger study participants. On average, the control responders in the 
WHH reported 8 percentage points (pp) more academic education than the 
figures retrieved from the OSF. The difference was the largest in the 25 to 34- 
year-old responders (+16pp) and smallest in the 45 to 54-year-olds (+4pp). 
With respect to parity, the controls in the WHH reported on average 9pp 
more often being parous relative to the data collected from the OSF. Again, 
the largest difference was observed in the youngest age group (25-34 years), 
with a +18pp difference. The smallest difference occurred in the age group of 
55-64 years, with a +5pp difference.  
On average, 24% of the FINRISK participants and 15% of the cases and 
17% of the controls in the WHH reported never having used hormonal 
contraceptives (excluding intrauterine devices in the WHH). Regarding the 
use of HR IUD, there were on average 7pp more reported ever-users among 
WHH controls than in the FINRISK, the difference being the largest in the 
youngest age group (+11pp), whereas the user-proportions in the age group 
55-64 years differed by only +1pp.  
Reporting of certain lifestyle factors, such as smoking, was surprisingly 
consistent between the examined surveys. Responders of all three surveys 
reported highly similar smoking prevalences, differing on average by only 2-
 54 
3pp among both cases and controls in the WHH.  While 11-12% of women in 
the AVTK and FINRISK studies reported never using alcohol, the 
corresponding average percentage was 7% in cases and 8% in controls of the 
WHH survey. WHH controls reported on average 6pp lower BMIs than 
AVTK and FINRISK participants. 
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10 DISCUSSION 
A significant positive association was observed between the use of HR IUD 
and the risk of breast cancer among post-menopausal women. Regarding the 
use of other hormonal contraceptives, the users’ risk of breast cancer was 
increased most in the younger women. As for the duration of use of other 
hormonal contraceptives, a significant association for longer usage (≥ 2 years 
vs. < 2 years) and breast cancer risk was observed in both analyzed age 
groups. 
Hormonal carcinogenesis is likely to be attributable to hormone receptor-
mediated responses. Progestogens are suggested to have the ability to 
stimulate cell proliferation in human breast cells, the magnitude of the effect 
being different in different synthetic progestogens. The presence of estrogen 
has been speculated to be essential for this progestogen-mediated cell 
proliferation, which does not support the hypothesis regarding the 
carcinogenic effect of hormonal contraception including only a progestogen 
component, such as the HR IUDs discussed here.71 Still, there is also 
evidence of genotoxic effects of progestogen and many progestogens have 
been shown to have estrogenic activity, which may play a role in the potential 
effect as well72.  
That the association between HR IUD use and increased risk of breast 
cancer was only observed in post-menopausal women is likely to reflect a 
latent phase before the onset of breast cancer. However, the possibility of 
selection bias cannot entirely be ruled out, as HR IUD may be a preferred 
method of contraception or used as part of hormone replacement therapy 
(HRT) among women with e.g. increased familial breast cancer risk. 
Regardless of the efforts made to control for both family history of breast 
cancer and use of HRT in the models, there is a possibility of residual 
confounding.   
The observed association between HR IUD use and risk of breast cancer 
among post-menopausal women supports the findings of the register-based 
study by Lyytinen et al. that suggested an increased risk of breast cancer in 
post-menopausal women using HR IUD67. It should be noted though that 
opposite results have also been reported in, for instance, the large 
questionnaire-based post-marketing study of Mirena©  levonorgestrel-
releasing intrauterine system use and the risk of breast cancer70. However, 
the follow-up of that study was rather short, a maximum of 10 years, 
therefore, not necessarily allowing an adequate induction period.  
The observed increase in breast cancer risk among recent HC users 
probably arises from the fact that the recent users are younger women in 
need of contraception. This finding is of special interest, considering the vast 
popularity of the use of contraceptive pills and findings also of null-
associations65,66. Our findings are still mostly in line with previous research 
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on the association between HC use and risk of breast cancer. A prospective 
study by Hunter et al. reported estimations of an increased breast cancer risk 
among younger (24-43 years) users of hormonal oral contraceptives62, and  
Rosenberg and colleagues concluded in their case-control study that the risk 
of breast cancer was elevated in women currently using HC64. Also Gierisch135 
and Beaber et al.136 reported significant associations between recent HC use 
and increased breast cancer risk.  
With respect to hair dye use and its association with the risk of breast 
cancer, the risk was 23% higher in ever-users of hair dye than in never-users. 
We also observed a significant association between earlier age at first hair 
dye and increased breast cancer risk when comparing two age groups 
(women who started at age 20-29 years and women who started at age 40 
years or over) and with pooled age groups.  The fact that no association was 
seen in those with first dye episode before the age of 20 years compared with 
women who started at ≥ 40 years of age (OR 1.06, 95% CI 0.96-1.16) implies, 
however, that age at first dye as such does not have an impact on the risk of 
breast cancer. The mechanism behind the potential association between hair 
dye use and breast cancer is unknown. 4-ABP has been suggested to have an 
ability to cause mutations in the genome 89. Also, the potential estrogenic 
activity of 4-ABP may have a role in the chain of events137.  
Earlier studies on the potential role of hair dye use in the risk of breast 
cancer have concluded with mixed results. While the research groups of 
Mendelsohn85, Green86, and Koenig87 reported null-associations, the results 
obtained in our study are mainly in line with the studies by Nasca81, Petro-
Nustas83 and Cook82, all of which reported increased breast cancer risk 
estimates for hair dye users.    
Some two-thirds of the women in both WHH and EET surveys had 
reportedly had a mammography before the start of organized screening at the 
age of 50 years. Having an opportunistic mammography was even more 
common among women who reported a family history of breast cancer and 
longer education.   
The estimates of the proportion of women having had an opportunistic 
mammography in our study were surprisingly high (>60%), although few 
previous studies exist with which to compare results. Earlier studies on use of 
opportunistic mammography in settings where organized and opportunistic 
screening systems co-exist are sparse, and the results vary greatly, with 
estimates ranging from e.g. 4% in Denmark138 to 64% in Spain139.  
It should be taken into account that self-reporting of screening attendance 
may overestimate true proportions, as suggested by Cronin et al., who 
observed a 16 percentage point higher uptake of mammography in Vermont 
women aged 40-49 years, when comparing self-reported figures with 
register-based data140.  The setting in which the above-mentioned study was 
performed obviously differs from the Finnish setting, as there is no 
population-based screening program in Vermont, but the estimate may be 
somewhat generalizable to Finnish women of the specific age group. Also a 
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meta-analysis on the accuracy of self-reported cancer screening concluded 
with a similar magnitude of overreporting of mammography attendance141.   
However, considering Study III, the proportion of women under 50 years of 
age with a history of mammography would still be unexpectedly high, even if 
one-fifth were removed from the estimate.  
Certain negative life events were associated with increased breast cancer-
specific mortality, while some positive events decreased the mortality. The 
effect was not seen with all specific events, but none showed effects against 
preliminary expectations of negative events having negative effects and 
positive events having good implications. Overall, the total stress score of the 
post-diagnostic negative life events increased breast cancer-specific mortality 
only slightly (by 4% per increment), but significantly. Meaningful 
associations regarding individual negative events were obtained for 
unemployment of spouse, relationship problems with spouse, and death of a 
close friend. 
The apparent associations between breast cancer-specific mortality and 
retirement and illness causing work disablement most likely only reflect the 
consequence of becoming a breast cancer case as the diagnosis could have led 
to early retirement or a period of sick leave. This assumption is supported by 
an observation in the further analysis, where the impact of retirement 
disappeared after age-group stratification – no effect was seen among 
women having reached the actual retirement age. Also, pre-diagnostic 
retirement did not have an effect on breast cancer-specific mortality.  
Earlier research on the effects of stressful life events on cancer survival or 
mortality is diverse with various methods. A large meta-analysis of the 
associations between stress and cancer determined that stress-related 
psychosocial factors were associated with poorer survival in cancer patients 
in 330 studies and 53 studies reported higher cancer mortality103. The results 
of Study IV suggested only post-diagnostic life events as having an impact on 
breast cancer-specific mortality; none of the pre-diagnostic negative life 
events appeared to have an effect. This latter finding supports the conclusion 
of Maunsell and colleagues that stressful life events experienced before the 
breast cancer diagnosis have no impact on breast cancer-specific mortality104. 
The observed positive association between post-diagnostic negative events 
and higher breast cancer-specific mortality, on the other hand, supplement 
the field of diverse research findings on the topic and second the conclusions 
reached by Chida et al. in the aforementioned meta-analysis103.  
As for positive life events, falling in love before the diagnosis and positive 
developments in hobbies after the diagnosis were found to be associated with 
lower breast cancer-specific mortality. Regarding the beneficial effect of 
having hobbies, our finding is in line with the study by Tominaga et al.106, 
where having a hobby and also a greater number of hobbies were associated 
with better survival of breast cancer patients. 
Changing levels of the body’s stress-related hormones are assumed to 
impact the essential immune functions, thereby also affecting the course of 
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the disease. For instance, natural killer cells (NK cells) are suggested to play a 
major role in many diseases by various mechanisms, including the immune 
surveillance of tumors. Certain stress hormones, including cortisol, 
adrenaline, catecholamine and epinephrine, have been hypothesized to 
impair the immune system by lowering the cytotoxicity of NK cells142–144.  The 
effect of NK cells on the initiation of cancer and accelerated tumor growth is 
rather well documented and NK cells are currently used in many new and 
experimental immunotherapeutic cancer treatments145,146.   A potential 
mechanism underlying the relationship between stress and cancer could be 
increased DNA damage caused by stress hormones147–149 . The causality 
between stress and cancer is not, however, straightforward. Some  studies 
suggest that certain levels of stress may even suppress tumor progression 
150,151 and that the effect is greatly dependent on stress-coping 
mechanisms152. 
10.1 ESTIMATIONS OF THE ATTRIBUTABLE FRACTIONS 
OF NOVEL EXPOSURES 
Use of HR IUD did not seem to impact the risk of breast cancer of women in 
the age group of 25-50 years. Use of other hormonal contraceptives, by 
contrast, was estimated to account for 24% of the risk.  In women aged 51-64 
years at survey, use of HR IUD was estimated to account for 32% of the 
breast cancer risk if exposed, some 7% being attributable to use of other 
hormonal contraceptives.  Combining these two, we end up with a 20% 
attributable fraction for use of exogenous hormones, which is very close to 
that reported by Barnes et al.56.  
Hair dye use was estimated to account for 19% of the breast cancer risk. 
While pre-diagnostic negative life events did not affect breast cancer-specific 
mortality, some 4% of breast cancer deaths were estimated to be attributable 
to negative events occurring after breast cancer diagnosis.  
10.2 STRENGTHS OF THE SUB STUDIES 
Population-based study design with a large sample size, and extensive, high-
quality cancer information are the most evident strengths of all of the sub 
studies in this work. Cancer data were not self-reported, data were collected 
nationwide, and there were basically no losses to follow up. An extensive set 
of questions in the WHH survey also provided good possibilities for adjusting 
for many potential confounders in the analysis. Owing to the high-quality 
registries and statistics in Finland, it was also possible to perform a validity 
assessment for the WHH survey. Based on this assessment, data from the 
WHH survey appeared to serve well, especially regarding use of hormonal 
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contraceptives and with respect to most of the background variables and 
potential confounders queried at the survey. 
10.3 POTENTIAL SOURCES OF BIAS 
Risk of bias in the WHH survey was likely to be greatest due to differences in 
response activity between breast cancer cases and controls. Socioeconomic 
status is also a potential modifying variable in many etiological studies, and 
thus, must be taken into account. Level of education is often used as a 
surrogate to estimate socioeconomic status, as in all sub studies here. Biased 
distribution of educational level of the survey responders naturally 
complicates assessment of the roles of factors commonly affected by the 
socioeconomic status, and accordingly, may reduce representativeness of the 
results. Also, information on responders’ occupation was missing, thus not 
allowing the assessment of potential occupational exposures and risks. 
As suggested earlier, women participating in health-related studies are 
likely to be more health-conscious and prone to a healthy lifestyle 
overall153,154. This is a problem concerning most survey-based studies and 
probably also affected this study. This should be taken into account when 
considering generalizability of the obtained results. However, surveys 
continue to be valuable sources of information on many potential risk factors 
and exposures related to lifestyle and behavior in general.  
Overall, recall bias is often identified as a likely source of bias in studies 
based on self-reported data. Naturally, magnitude and direction of bias are 
greatly dependent on the nature of the survey questions. Risk of recall bias is 
relatively large regarding, for example, questions on hair dye use in Study II. 
It might have been difficult for the responders to estimate lifetime hair dye 
episodes or to determine the different dye types used.  Women with breast 
cancer may also be prone to overestimate their hair dye use if they saw it as a 
potential causal component of their disease. Reporting ever- vs. never-use of 
hair dyes is, however, not likely to be as susceptible to bias, as it is easier to 
remember and the chance of cases and controls reporting usage differently is 
lower. A similar type of recall bias might also have affected Study IV. Some 
life events may have been difficult to assign to a certain time period. This 
may have consequently affected categorization of the events as pre- or post-
diagnostic. Also, it should be noted that existing depression might influence 
the way of perception when encountering other life stresses. Usually mildly 
experienced events may then be overwhelming or in the other extremity, 
become ignored. Either way, it may severely impact the experience and thus 
also bias reporting of it.  
Recall bias was not a major concern in Study III, which investigated the 
prevalence of opportunistic mammography, as women probably remembered 
the somewhat painful procedure. Overall in Study III, the possibility of 
selection bias was likely to be greater in the WHH survey due to study design. 
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There, the WHH study population was formed from the controls of breast 
cancer cases. Still, the observed effect estimates did not differ much between 
the WHH and EET surveys, suggesting that role of selection bias was not very 
big.     
It should also be noted that there is major variation in times between 
cases’ diagnosis and the survey and this may affect the recall of the events 
and their timings in Study IV.  While the minimum time between breast 
cancer diagnosis and the WHH survey was 1 year, the maximum was 9.5 
years. The median interval was 5.5 years. The retrospective nature of the 
WHH survey also creates potential for selection bias, as we inevitably miss 
the most aggressive types of cancers. It is also possible that a person recently 
diagnosed with the disease in question is more devoted and motivated to 
participate in a study concerning one’s disease, and possibly also more prone 
to over-reporting exposures that may be considered to have an impact on the 
disease onset. This may especially apply to Study I, where the title of the 
WHH survey may have led responders to strongly associate hormone use 
with breast cancer, hence affecting their survey responses on the topic. 
Bias concerning case-control ascertainment was considered to be 
insignificant, as FCR coverage is nearly complete134.  
10.4 BREAST CANCER – IS IT A PHENOMENON OF 
WESTERN SOCIETY? 
Attempts to modify people’s beliefs regarding risk avoidance and preferred 
behavioral patterns as well as to overcome ignorance are among the most 
essential public health objectives. It is assumed that a person changes his/her 
behavior once he/she is made aware of the potential dangers or benefits of a 
certain type of behavior. The success of the resulting behavior change is 
uncertain.  It is likely that the intentions of more healthy behavior are often 
defeated by busy everyday life, and it should be remembered that people 
have priorities in life beyond pursuing good health5. It is thus argued that 
health interventions should focus on the recognized pressure points that 
generate health behaviors. An example of such a pressure point could be 
found in the statutes and more importantly in the informal practices and 
work-place sub cultures that regulate working times and lunch, and other 
breaks. The demanding, performance-oriented culture of today’s working life 
is apt to foster unhealthy diet and sedentary behavior, which over time 
become normalized and also routine in other areas of life. Targeted, well-
grounded policy measures in, for instance, work time legislation may have a 
marked effect on overall behavioral patterns with respect to eating, among 
other things, as discussed by Dixon.5 Dixon also states that “if cultural norms 
are contributing to the rise in health risks such as obesity and the 
persistence of smoking, then it follows that cultural forces need to be 
unleashed to counteract their present trajectories”. Governments, religious 
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institutions, the commercial sector, etc., all influence the ideas and practices 
comprising the cultural framework, and thus, also have the ability to induce 
or contribute to cultural changes, and through these, behavioral changes.5 
Olsen states that a multidisciplinary, mixed-method approach in health 
research would be key to a more nuanced understanding of human behavior 
and disease patterns155. Medical anthropologists argue that current 
epidemiology is merely focused on isolated disease risk factors, separated 
from broader context, disregarding the societal determinants of disease25,155. 
The aim of the following paragraphs is to place the main findings of the sub 
studies into the cultural and societal context of today’s Finland.  
Use of HR IUD is especially common in Finland, which may in part be 
related to the history of first such device being invented in Finland, and thus 
being in a spotlight. While oral contraceptives hold their first place position 
in hormonal contraceptive use, intrauterine devices come second156.  
Increased use of hormonal contraceptives in Western countries is naturally 
related to the need for longer periods of contraception, as increasingly fewer 
children are had at an increasingly older age. Reasons for this are diverse.  
Education for a profession takes longer than before, as university-level 
education has become “the norm” for many people, and it is customary for 
both parents to work. People enter work life at a later age than a few decades 
ago, and childbearing is often delayed until an established position in work 
life and financial security have been obtained. Also, social pressure of getting 
married and having children – created traditionally by parents and other 
relatives - perhaps no longer exists in Western societies to the same degree as 
before. The patent of the world-leading HR IUD brand Mirena© expired at 
the end of 2015, and it remains to be seen how the markets react; will there 
be more competition with new less expensive products, potentially leading to 
increasing numbers of HR IUD users. The Annual Report 2015 of the 
Mirena© manufacturer Bayer indicates that the sales of Mirena© have been 
increasing in the USA, ranking among their bestselling pharmaceutical 
products157. Reliable information on the long-term effects of HR IUD use is 
crucial. 
Use of hair dyes, on the other hand, is among the most stereotypic 
features of Westernization and falls into the same category as other ideals 
related to the concept of beauty and appearance, including fashion diets and 
a constant flow of new methods and products for beauty care and make-up.  
Western culture idealizes youth, beauty and vitality and many related 
products and modes of behavior in pursuit of these ideals cannot 
unambiguously be deemed safe.  Results obtained in Study II suggest that the 
role of hair dye use may be substantial in etiology of breast cancer. Taking 
the popularity of hair dye use into account, the impact in public health could 
also be considerable, even if the increase in risk of breast cancer attributed to 
hair dye use is small at the individual level. 
A large proportion of women having had an opportunistic mammography 
before organized breast cancer screening age is probably one the most recent 
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effects of modernization and a manifestation of a medicalized welfare society. 
Access to public health-care, occupational health care and private 
gynecologists is easy and affordable for many women. In a comparative study 
on performance of organized and opportunistic breast cancer screening, 
Bihrmann and colleagues reported significantly higher sensitivity of 
organized breast cancer screening compared with opportunistic screening, 
specificity being relatively similar in both. Considering this, they 
recommended implementation of population-based breast screening 
programs, as also recommended in the European guidelines.158 The problem 
in many developed countries, however, is the mixed model of two co-existing 
systems, and a starting point for the overall benefit-harm evaluation of breast 
cancer screenings would be better reporting systems for opportunistic 
mammography. This would be highly useful also in Finland. 
Research on the effects of stress in health and disease has increased over 
the past years. Regardless of the already rather convincing evidence of the 
negative impact of stress on health, efficient and long-ranging public health 
interventions are lacking. This may be due to the non-measurable nature of 
the exposure or simply the lack of concrete intervention methods. Of all the 
investigated exposures in this study, stress probably has the most significant 
role in terms of overall health. Actions and structures of society have become 
immensely complex and diverse, and it is likely that the human body and 
mind cannot fully keep track of the changes and adapt to the ever-changing 
environment.  
The high incidence of breast cancer in Western countries may reflect 
physical maladaptation to immense, continuous cultural change. As societies 
are becoming more and more complex and multidimensional, it is 
increasingly difficult to identify factors affecting disease outcomes. Many 
contributing environmental and behavioral factors regarding breast cancer 
have, however, been identified, and alongside the ongoing preventive public 
health measures initiated in Western societies, more efforts should be 
directed to public health in developing countries. The effects of 
modernization in these countries are just starting to become apparent, and 
timing would be right for efficient health interventions.    
Our studies suggested significant associations between use of both hair 
dyes and hormonal contraceptives and an elevated risk of breast cancer. Such 
exposures are ideal examples of modernization and the Western lifestyle and 
the accompanying downsides.  The effects of certain major life events on 
breast cancer-specific mortality, on the other hand, exemplify the fact that 
while great strides have been made in breast cancer treatment, 
uncontrollable factors also play a role. The key is to identify such factors and 
if they are not modifiable, they can at least be taken into account in 
recognizing potential risk groups and in planning treatment.   
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11 SUMMARY AND CONCLUSIONS 
The purpose of this study was to investigate modern, less known Western 
society lifestyle-related factors affecting breast cancer outcomes. A secondary 
aim was to explore the change in the overall breast cancer risk factor 
spectrum and to evaluate it as part of a larger cultural and societal 
framework.   
The observed increase in breast cancer burden in Finland and elsewhere 
is undoubtedly greatly influenced by modernization and modes of behavior 
related to changes in the Western culture. Women entering work force and 
its implications for reproduction patterns, excessive use of chemicals, a 
demanding stressful society, increased use of alcohol, and overall sedentary 
lifestyle are all reflective of Western lifestyle. In addition to the evident 
differences in behavioral patterns between Western and non-Western 
cultures producing most of the variation in global breast cancer incidence 
and mortality, there are likely to be other factors contributing to the 
differences seen in the known epidemiology of breast cancer.  
The current landscape of breast cancer risk factors of Finnish women is 
constructed of the well-known, classical factors detected also in the sub 
studies here and more novel exposures. Later age at first delivery, low birth 
rate, sedentary life style, increasing alcohol use and overweight may be 
considered established risk factors and these are, as suggested by the 
findings of the sub studies, more and more often complemented by the 
effects produced by the directly measurable factors like use of exogenous 
hormones and cosmetics such as hair dyes. Other complex factors, including 
stressful daily life, add to the burden. The surprisingly popular opportunistic 
mammography may also impact breast cancer susceptibility by increasing 
radiation body burden, when added to all other medical sources of radiation. 
The latter two were not evaluated in the framework of this thesis, but are 
intriguing topics for future analysis. 
When looking at the big picture of the etiology of breast cancer, we can 
see many changes in the contributing risk factors over time. According to 
current knowledge, prevalence of many known breast cancer risk factors has 
increased markedly over the past few decades. Some of these are directly 
modifiable, such as physical activity, overweight, and alcohol and hormone 
use, while others, e.g. reproduction behavior, are more complex. Promotion 
of a healthy lifestyle, specifically regarding physical activity, overweight, and 
alcohol use, should receive more attention and there should be a clear 
message of its importance also in breast cancer prevention – at present, the 
focus tends to be on other diseases, e.g. other cancers, cardiovascular 
diseases, or mental health.  In contrast, it is more difficult to make 
recommendations on reproduction behavior. Women can, and should, 
however, be made aware of the modes of behavior resulting in an increased 
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risk of breast cancer so that they can make informed choices in family 
planning. Use of hormonal contraceptives is tightly linked to this and women 
ought to be more comprehensively informed of the risks related to their 
usage. While the evidence for use of combined oral contraceptives in 
increased risk of breast cancer is strong, research on the association between 
HR IUD use and breast cancer risk is still sparse – our study clearly 
suggesting a need for this. Further studies with other populations and a 
prospective study design are strongly recommended, taking into 
consideration the increasing use of HR IUD. Also, longer exclusive 
breastfeeding would be of benefit considering the risk of breast cancer and 
this should be more efficiently promoted – as mentioned, exclusive 
breastfeeding up to the recommended age of 6 months is very rare in 
Finland.  Not only would this benefit the child, but it would also lower the 
mother’s risk of breast cancer. 
Use of chemicals, including cosmetics, increases the body burden of 
potentially toxic and carcinogenic substances. Caution is warranted in use of 
all chemicals and there is a need for stricter control of sales and use of 
personal hair dye products. Usage is currently not recommended for those 
aged under 16 years in the EU, but monitoring is insufficient.  More 
responsibility should also be directed to regulatory authorities on the safety 
of these products, as more research on their accumulation in the body and 
long-term effects is needed. Risk evaluation of hair dye substances should be 
carried out by an organization independent from the manufacturing 
industry.   
With respect to opportunistic mammography, it would be important to 
guide and restrict the wide use of non-organized activity in healthy women 
without clinical indications or significant familial cancer burden. It would be 
useful to start registering the examinations in order to be able to take these 
into account when evaluating the organized breast cancer screening program. 
High usage of opportunistic mammography may undermine the organized 
screening program and complicate proper assessments of its functions and 
effectiveness. It should also be noted that women may be unaware of the 
risks of excessive use of mammography in terms of accumulating radiation 
burden. The negative aspects of false-positive findings should also be 
disclosed. Likewise, it is important to increase women’s knowledge of when 
there is reason to suspect a true familial risk of breast cancer, as opposed to 
sporadic breast cancer cases in the family, which warrant no additional worry 
or preventive measures.  
In addition, there are biological factors, including age at menarche and 
menopause, where the change is a result from long-term societal evolution 
and cannot be directly modified by an individual. A hectic, stressful lifestyle 
is also so tightly bound to the surrounding societal norms and modernization 
that it may prove difficult to make drastic changes to it. Better understanding 
by health professionals of the possible adverse effects of stressful life events – 
and the potential positive impact of positive events - would provide a starting 
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point for more holistic health-care planning, disease prevention, and 
efficient, personalized treatment. It is well-known that there is an excess risk 
of death even 15 years after breast cancer diagnosis, and the follow up should 
be extended beyond the routine mammography, including also mental well-
being and recovery.  
It should be noted, however, that modernization and its implications can 
also be looked at from a different perspective and it cannot be considered as 
resulting only in emergence of new potential risk factors. There has been 
great improvements in women's position in a Finnish society overall and it is 
evident that some of the elements discussed here have also resulted in 
remarkable positive developments in women's life. As mentioned, for 
instance matters of reproduction are complex and making steady 
recommendations on them may be considered inappropriate or 
unconventional. As discussed earlier, people often have priorities in life other 
than solely pursuing good health and they may be willing to make choices 
that are known to possess additional risks on certain health outcomes. It is of 
health professionals’ responsibility to make sure they are informed choices.  
From the epidemiological point of view, while in the mid-1900s breast 
cancer in Finland was a rare disease and its etiology was likely based on 
fewer risk factors, today it is a rapidly increasing disease of women from all 
walks of life, and with much larger variation in the risk factor spectrum. This 
study provides new information concerning some less studied factors 
affecting breast cancer risk and survival from it. These findings combined 
with known factors should improve prevention efforts.  The primary target of 
breast cancer prevention from the epidemiological perspective is to provide 
new research-based information for both women and policy makers to 
advocate healthier choices in life.  
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